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ABSTRACT 
       Cell-to-cell communication by bacteria is essential for the regulation of gene expression 
important in colonization, biofilm formation, virulence and other processes. This communication 
is called “quorum-sensing” and is mediated by small molecules called autoinducers. One major 
class of autoinducers used by gram-negative bacteria is N-acyl homoserine lactones (AHL’s). 
Enzymes capable of disrupting this communication are called “quorum-quenching” catalysts and 
have proven to be invaluable biochemical tools for understanding quorum-sensing pathways. 
Quorum-quenching enzymes hold promise for application in anti-biofouling, agriculture, 
aquaculture, bioremediation and other synthetic biology settings. However, the mechanisms that 
these enzymes use to recognize and process their substrates are not well characterized. A better 
understanding of selectivity and catalysis would enable the production of variant enzymes to 
recognize specific quorum-sensing signals to serve as catalysts for various applications. 
     Aminotransferases are a class of pyridoxal-5’-phosphate (PLP)-dependent enzymes that 
catalyze a myriad of biochemical reactions involved in several metabolic processes. The 
importance of these enzymes is further underscored because some of them have been identified 
as drug targets. For example, inhibition of γ-aminobutyric acid aminotransferase (GABA-AT) 
was proven effective in the treatment of many neurological disorders, and inhibition of ornithine 
aminotransferase (OAT) was shown to suppress the growth of hepatocellular carcinoma (HCC). 
Potent mechanism-based inactivators can be rationally designed against these PLP-dependent 
drug targets, but one of the remaining challenges is the lack of selectivity against other PLP-
 xiv 
dependent off-target enzymes such as aspartate aminotransferase. A better understanding of 
enzyme selectivity and mechanism would enable the design of molecules capable of displaying 
desirable specificity of inactivation discerning drug-targets and off-targets. 
      The goal of this dissertation is to provide better understanding of selectivity and catalysis in 
quorum-quenching enzymes, and selectivity and mechanisms of PLP-dependent 
aminotransferases. The structural and biochemical characterization of AidC, an N-acyl 
homoserine lactone lactonase, was carried out using X-ray crystallography and other biochemical 
techniques. The selectivity of a mechanism-based inactivator was tested in a PLP-dependent 
aminotransferase drug-target (OAT) and off-target (Asp-AT) using X-ray crystallography and 
enzyme assays. The proposed mechanism was confirmed by high-resolution mass spectrometry.  
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CHAPTER ONE  
INTRODUCTION 
Structural and Biochemical Characterization of AidC 
Quorum-sensing  
     Cell-to-cell communication by bacteria is essential for coordinating the regulation of 
numerous genes important in colonization, biofilm formation, virulence, survival in competitive 
environments, and other processes. Such communication is called ‘quorum-sensing’. Quorum 
sensing bacteria regulate gene expression using chemical signal molecules called autoinducers 
(AI). These autoinducers are produced within the cell and can diffuse across the cell membrane. 
Once the concentration outside the cell has reached a threshold, they bind cytoplasmic receptors 
and regulate gene expression in the QS regulon.1,2 
     The first described quorum-sensing system is that of bioluminescent gram-negative bacterium 
Vibrio fischeri3. Expression of the luciferase operon (luxICDABE) is controlled by two proteins, 
LuxI and LuxR. LuxI is the autoinducer synthase, which produces the acyl-homoserine lactone 
(AHL) and LuxR is the cytoplasmic autoinducer receptor/DNA-binding transcription activator.4 
A large number of other gram-negative bacteria possess LuxIR-type proteins and communicate 
with AHL signals5 (Figure 1). These systems are used predominately for intraspecies 
communication and extreme specificity is known to exist between the LuxR proteins and their 
AHL signals.  
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Figure 1. C4-N-acyl-L-homoserine lactone (AHL) 
Gram-positive bacteria communicate using modified oligopeptides as signals and membrane-
bound sensor histidine kinases as receptors1. Each gram-positive bacterium uses a signal 
different from other bacterium and has receptors that are extremely specific. Thus, like in gram-
negative LuxIR systems, these peptide quorum-sensing systems are understood to be involved in 
intraspecies communication.  
Quorum-quenching 
    The role of quorum-sensing in bacteria appears to be control of gene expression. In 
environments where bacteria compete for limited resources, the ability to disrupt this quorum-
sensing may give some bacteria an advantage over another bacterial species that relies on 
quorum-sensing. Or, a host’s ability to interfere with bacterial quorum-sensing may be crucial to 
prevent virulence caused by colonization of the pathogen1. Therefore, it is not surprising that 
mechanisms have evolved that have the ability to disrupt this bacterial cell-to-cell 
communication, called quorum-quenching. Enzymes capable of blocking these signaling 
pathways are referred to as quorum-quenching enzymes or quorum-quenching catalysts. Several 
quorum-quenching strategies have been identified in nature, and one of them includes the use of 
AHL degrading enzymes.  
O
N
H
H
O
O
 3 
Quorum-quenching enzymes 
     Based on the chemical structure of AHLs, reports suggests that four different ways of 
degrading an AHL may occur by lactonase, decarboxylase, acylase and deaminase6. Of these 
only two types of quorum-quenching enzymes have been reported, namely lactonase and 
acylase7. The AHL lactonases, are very specific in recognizing the lactone ring and catalyzing a 
ring-opening reaction by hydrolyzing the lactones to their corresponding γ-hydroxy acid, a 
product that can no longer be used for signaling8,9. AHL acylases are very specific for the N–acyl 
substituent and catalyze amide hydrolysis10. These reactions are shown in Scheme 1.  The 
research work in this dissertation will focus only on AHL lactonases.  
 
 
Scheme1: General reaction scheme for the conversion of N-acylhomoserine lactones by an acylase or 
lactonase to their corresponding homoserine lactone and γ-hydroxy acid respectively. 
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N-Acyl-L-homoserine lactone (AHL) Lactonases 
      The first reported quorum-quenching enzyme was AiiA (autoinducer inactivating protein A) 
from a Bacillus sp. strain 240B1 and is an AHL hydrolase9. The amino acid sequence shows a 
conserved sequence motif of HXHXDH H, similar to the metal binding motif in the metallo-β-
lactamase superfamily of proteins9. Initial reports suggested that AHL lactonases were metal 
independent11; however, subsequent work proved AiiA contains two equivalents of tightly-bound 
zinc ions that are found in a dinuclear zinc cluster at the active site, and the metal ions play an 
essential role in catalysis12,13.  A series of papers have been published, using product-bound 
structures, molecular modeling and site-directed mutagenesis which support the role of each zinc 
ion that is consistent with the rest of the super family14,15.  
Substrate specificity in AiiA  
     AiiA is specific for the ring structure in N-acyl-HSLs, but can process various lengths and 
substitutions on the acyl chain11,12. Figure 2 represents a list of substrates that can be processed 
by AiiA.  
 
Figure 2. AiiA substrates 
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AiiA is not very selective for the length or substitution of AHL’s, although longer alkyl chains 
(n ≥ 4) are preferred11,15. The promiscuity of AiiA is proposed to be derived from the wide, 
shallow, hydrophobic groove in which the N-acyl substituent of the product is observed to 
bind14,15 (Figure 3). Initially, AiiA did not appear to have any substrate-binding loops that 
facilitate ligand binding. However, the structure of an AiiA mutant (F107W) bound to a ring-
opened product of a longer AHL substrate16 (C10-HSL) shows, the hydrophobic N-acyl 
substituent does not bind to the same groove as the shorter C6-HSL product, but rather extends 
through a different channel that is formed by closure of a loop that was previously disordered17, 
making a ‘phenylalanine-clamp’ that is proposed to hold longer ligands. (Figure3)  
 
Figure 3. Substrate binding pocket in AiiA. Channel 1 represents the wide, shallow groove used by AiiA 
to process shorter acyl tails (from PDB:3DHB). Channel 2 represents the alternate binding site for the N-
alkyl substituent in a phenylalanine-clamp (from PDB:4J5H) 
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A proposed catalytic mechanism of AiiA 
     Based on structural and functional studies, a catalytic mechanism has been proposed for AiiA 
(Figure 4).14,15 The crystal structures of AiiA (Figure 4: I)13 and AiiA bound to product (Figure 
4:V)14,15 represent two states in the catalytic cycle. One unusual feature of the proposed 
mechanism is the use of Zn2 as a superacid to stabilize the anionic charge that develops on the 
leaving group oxygen (Figure 4: IV). In AiiA studies using different metalloforms, a strong thio-
effect is reported on Kcat when thiolactones are used as substrates18. This finding supports a 
kinetically significant interaction of the leaving group, which is consistent with the intermediate 
IV in Figure 4. Structural data supports three states of the enzyme represented as I, IV and V in 
the proposed mechanism in Figure 4.  
 
Figure 4. Proposed catalytic mechanism of dizinc AiiA. Structural data supports the species represented in 
I, IV and V.  
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AidC a quorum-quencing AHL lactonase from Chryseobacterium sp.  
     Recently, AidC was reported as a quorum-quenching enzyme because of its ability to 
catalyzes the hydrolytic ring opening of multiple N-acyl homoserine lactone (AHL) substrates19.  
Analysis of protein sequence alignments revealed that AidC is homologous to other AHL 
lactonases found in the metallo-hydrolase / oxidoreductase superfamily, and shares a conserved 
dinuclear metal binding motif. The most striking feature of AidC is its reported KM values.  All 
previously characterized wild-type AHL lactonases have KM values ≥ 1.4 mM14-16, with the 
exception of MomL (440 µM; Muricauda olearia marine AHL lactonase).17  In contrast, the 
reported KM values for AidC are approximately ≥ 24-fold lower: 46 - 72 µM19. The lower KM 
values of AidC are of interest since a better understanding of how quorum-quenching enzymes 
recognize and process their substrates can enable their appropriate selection and optimization as 
biochemical tools and help in the proposed development of this class of enzymes as therapeutic, 
anti-infective, and anti-biofouling proteins.3-7  
Limitations of quorum-quenching lactonases and objectives for this dissertation 
    The current quorum-quenching lactonases are not well understood. Their broad substrate 
specificity limits their potential applications, and their impact on survival in competitive 
environments is not well understood. A better understanding of the basis of selectivity and 
catalysis would enable the production of variant enzymes tuned to recognize specific quorum-
sensing signals to serve as more precise biochemical probes, and as catalysts for other 
applications. The work in my dissertation directly addresses gaps in our knowledge of quorum-
quenching AHL lactonases.  
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In the first part of this thesis I have worked on the structural and biochemical characterization 
of AidC. Structural studies reveal a novel structure of AidC, and a complex structure of AidC 
bound to its product.  Steady-state kinetic experiments provide information about substrate 
specificity and show AidC is the most efficient quorum-quenching enzyme characterized to date. 
Implications on the catalytic mechanism of quorum-quenching enzymes are discussed.  
Selective targeting by a mechanism-based inactivator against PLP-dependent aminotransferases 
Aminotransferases 
      Pyridoxal-5’-phosphate (PLP), the active form of vitamin B6, is an important coenzyme in 
many enzymatic reactions20. Aminotransferases are a class of PLP-dependent enzymes that 
catalyze myriad biochemical reactions involving amino acid metabolism, amino acid-derived 
metabolites, and the biosynthesis of amine-containing compounds. Aminotransferases catalyze 
the reversible transfer of an amino group from a substrate to an α-keto acid acceptor21. All 
aminotransferases undergo a similar catalytic mechanism, in which two coupled half-reactions 
are required for one transamination cycle. This is commonly referred to as a “ping-pong” 
mechanism. Both reactions are often catalyzed by a basic lysine residue and involve the 
tautomerization of an aldimine formed between the substrate and PLP. In the first half-reaction, 
the cofactor PLP accepts the amino group from the substrate and is converted to the 
pyridoxamine 5’-phosphate (PMP) form, and the substrate becomes the corresponding carbonyl 
compound. The second half-reaction involves the reactivation of the enzyme in a similar manner, 
by transferring the amino group from PMP to a suitable carbonyl-containing acceptor 
compound20(Scheme 2). 
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Scheme 2. General aminotransferase reaction.  The scheme represents two coupled half reactions required 
for one complete transamination cycle.  
Aminotransferase as drug-targets 
     Aminotransferases are vital for because they catalyze biochemical processes involving amino 
acid metabolism20. Their importance is further highlighted because they are important drug-
targets for the treatment of diseases. The work in this thesis focuses on two of these drug-targets 
γ-aminobutyric acid aminotransferase (GABA-AT) and ornithine aminotransferase (OAT).   
γ-Aminobutyric acid aminotransferase (GABA-AT; EC 2.6.1.19) is a PLP-dependent enzyme, 
found in many organs, including brain, liver, kidney, and pancreas; however, it is present at 
higher specific activity in glial cells and presynaptic neurons22. It catalyzes the transfer of an 
amino group of GABA to α-ketoglutarate, producing succinic semi aldehyde and L-glutamate 
(Scheme 3). Abnormally low levels of GABA in the brain have been associated with 
neurological disorders including epilepsy, Parkinson’s disease, Huntington’s disease and 
Alzheimer’s diseases23. Thus, inhibition of GABA-AT is considered as a drug target for 
developing treatments for these neurological diseases and has been studied in detail.  
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 Scheme 3. General Mechanism of GABA-AT and OAT 
Ornithine aminotransferase, OAT (L-ornithine 2-oxoacid d- aminotransferase, EC 2.6.1.13) is a 
pyridoxal 5-phosphate (PLP) dependent enzyme, found in the mitochondrial matrix of most 
human and animal tissues24 and, catalyzes the transfer of  the δ-amino group of L-ornithine to α-
ketoglutarate, forming glutamate γ-semialdehyde and  
      L-glutamate (Scheme 3). It was recently discovered that ornithine aminotransferase (OAT), 
is highly upregulated in hepatocellular carcinoma (HCC), which is the second most common 
cause of death from cancer in men worldwide25. Inhibition of overexpressed OAT was shown to 
suppress the growth of HCC tumors26. Inhibition of OAT is proposed to also be beneficial in 
treating hyperornithinia27 and, is being investigated as a target in chemotherapeutic drug 
development. 
Aminotransferase as off-targets 
The reactions catalyzed by PLP dependent aminotransferases appear diverse, but they all share a 
similar catalytic mechanism28. This makes it challenging to design specific inactivators of 
enzyme drug targets like GABA-AT and OAT without effecting off-target PLP dependent 
aminotransferases. For the purpose of this work we studied aspartate aminotransferase (Asp-AT) 
as a model off-target enzyme.  
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Aspartate aminotransferase is a PLP dependent enzyme that catalyzes a transamination 
reaction between aspartate and α-ketoglutarate to oxaloacetate and L-glutamate. (Scheme 4)28 
During the enzyme catalyzed reaction, the cofactor is interconverted between its PLP and 
pyridoxamine (PMP) form. The transfer of the amino group catalyzed by AspAT is crucial in 
both amino acid degradation and biosynthesis. Therefore, when designing an inactivator for PLP 
dependent drug-targets any molecule that also inhibits/inactivates Asp-AT irreversibly even at 
low concentrations may not be a promising molecule for further pharmacological development.  
 
Scheme 4. General Mechanism of Aspartate aminotransferase 
Similarities between Asp-AT, OAT and GABA-AT: General mechanism and structure  
     All aminotransferases follow the same initial catalytic mechanism, except for the structure of 
the substrate that is recognized and the resulting product. The specific steps of the first half of the 
reaction are shown in Scheme 5 and the second half proceeds in the reverse manner20,28.  
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Scheme 5. General mechanism of aminotransferases 
First, the amino group of the catalytic Lys forms a Schiff base with the aldehyde carbon to 
generate an internal aldimine. The amino group of Lys in displaced by the amino group of the 
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substrate via nucleophilic attack to form the external aldimine. The hydrogen attached to the 
alpha-carbon of the substrate in then abstracted (Lys is proposed as the proton acceptor) to form 
a quinonoid intermediate. The quinonoid is reprotonated, but now at the aldehyde carbon, to 
form the ketimine intermediate. Finally, the ketimine is hydrolyzed to form PMP and 
oxaloacetate. This reaction is proposed to have several rate-determining steps29, however, it is 
shown substrate binding drives the catalytic reaction30.  
GABA-AT, OAT and, Asp-AT share the same initial catalytic mechanism. Therefore, it is not 
surprising that they share a significant amount of structural homology. Storici et al31. first 
reported the crystal structure of GABA-AT from pig liver, which is known to be 96% identical to 
human brain GABA-AT. The crystal structure of human recombinant OAT was first reported by 
Shen et al.32 In its native form, the PLP cofactor is linked to a lysine residue in the active site, as 
shown in Scheme 5. An overlap of the crystal structures of OAT, GABA-AT, and Asp-AT show 
that they all share a similar Class I aminotransferase protein fold33 and PLP interacts similarly 
with the conserved active-site residues (Figure 5). Also, the phosphate group of the cofactor 
provides a firm anchor to the region in the active site known as the “phosphate-binding cup.”34 
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Figure 5. Comparison of the structure of Asp-AT(green), GABA-AT(blue) and OAT (pink). A. Overall 
secondary structure of GABA-AT (PDB accession code 1OHV), OAT (PDB accession code 1OHV) and, 
Asp-AT (PDB accession code 1ARG). B. The overlap of active sites shows similarities in the position of 
important catalytic residues Lys and Arg.  
Mechanism-based enzyme inactivation 
     The similarities in the structure and mechanism of OAT, GABA-AT and Asp-AT make it 
challenging to design a drug molecule that can specifically inhibit only one drug-target without 
binding to other PLP dependent enzymes and off-targets. One way to overcome this difficulty is 
by designing mechanism-based inactivators. According to Silverman35, a mechanism based 
inactivator is an unreactive compound who’s structure resembles that of the substrate or product 
of the target enzyme and, undergoes a catalytic transformation by the enzyme to a species, that 
prior to release from the active site causes inactivation of the enzyme. Mechanism-based 
inactivators have a higher chance of being selective because they require the distinct catalytic 
mechanism of the enzyme to occur before inactivation. The Silverman group has designed a 
library of compounds (Figure 6) that are GABA analogs and mechanism-based inactivators for 
GABA-AT. For the purpose of this work we test (1R,3S,4S)-3amino-4-fluorocyclopentane-1-
carboxylicacid (FCP) (Figure 6: 12) on OAT a drug-target and Asp-AT a model off-target. 
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 Figure 6. GABA analogs as mechanism-based enzyme inactivators 
 (1R,3S,4S)-3amino-4-fluorocyclopentane-1-carboxylicacid (FCP) as a mechanism based 
inactivator and objectives for this dissertation 
      GABA-AT and OAT share a similar catalytic mechanism, overall structure and, have similar 
catalytic residues in their active site23. Therefore, it is not surprising that some mechanism-based 
inactivators of GABA-AT also inactivate OAT. (1R,3S,4S)-3amino-4-fluorocyclopentane-1-
carboxylicacid (FCP) is a known inactivator of GABA-AT. Previously Storici et al36 reported the 
inactivation of GABA-AT by FCP with the crystal structure of the inactivated enzyme showing 
the adduct derived from the mechanism of inactivation. FCP is also reported as an inactivator of 
OAT26, but no information is available about its detailed mechanism of inactivation. An 
understanding of the mechanistic differences between GABA-AT and OAT can help in the 
design of selective inhibitors of OAT over GABA-AT.  
      For the purpose of this dissertation I investigated the mechanism by which FCP inactivates 
OAT, and tested the effects of FCP on a PLP-dependent off-target Asp-AT. This study serves as 
a proof-of-principle that new OAT inactivators could be developed from GABA analogues, 
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without targeting other off-target PLP-dependent enzymes. In this study, we obtained the 
crystal structure of inactivated OAT by FCP and provide implications about the mechanism. We 
also report the crystal structures of the off-target Asp-AT in complex with FCP in the presence as 
well as in the absence of α-ketoglutarate. The crystal structures of Asp-AT in complex with FCP, 
along with inhibition assays and high resolution mass spectrometry, support the turnover of FCP 
by Asp-AT and the proposed mechanism.  
 
CHAPTER TWO 
STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF AidC, A QUORUM-
QUENCHING LACTONASE WITH ATYPICAL SELECTIVITY 
Summary 
     Quorum-quenching catalysts are of interest for potential application as biochemical tools to 
interrogate interbacterial communication pathways, as anti-biofouling agents, and as anti-
infective agents in plants and animals.  Herein, the structure and function of AidC, an N-acyl-L-
homoserine (AHL) lactonase from Chryseobacterium, is characterized.  Steady-state kinetics 
show that zinc-supplemented AidC is one of the most efficient wild-type quorum-quenching 
enzymes characterized to date, with a kcat/KM value of approximately 2 × 106 M-1s-1 for N-
heptanoyl-L-homoserine lactone.  The enzyme has stricter substrate selectivity and significantly 
lower KM values (ca. 50 µM for preferred substrates) than typical AHL lactonases (ca. > 1 mM).  
X-ray crystal structures of AidC alone, and with the product N-hexanoyl-L-homoserine were 
determined at resolutions of 1.09 and 1.67 Å, respectively.  Each structure displays as a dimer, 
and dimeric oligiomerization was also observed in solution by size-exclusion chromatography 
coupled with multi-angle light scattering.  The structures reveal two atypical features as 
compared to previously characterized AHL lactonases: a ‘kinked’ α-helix that forms part of a 
closed binding pocket which provides affinity and enforces selectivity for AHL substrates, and 
an active-site His substitution that is usually found in a homologous family of 
phosphodiesterases.  Implications for the catalytic mechanism of AHL lactonases are discussed.
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INTRODUCTION  
     One of the most prominent social behaviors displayed by bacteria is quorum-sensing, the 
ability to coordinate gene expression in response to population density through the production 
and detection of interbacterial signaling molecules such as the N-acyl-L-homoserine lactones 
(AHLs).37 Enzymes capable of blocking these signaling pathways, called quorum-quenching 
enzymes, are important biochemical tools for probing quorum-sensing pathways.38 They also 
hold considerable promise as reagents to prevent marine and membrane biofouling, as treatments 
to prevent costly infections of plants and fish, as potential protein therapeutics, and possibly as 
tools to manipulate interactions between diverse microbes.7,39–42 Some of the quorum-quenching 
enzymes most widely used for such applications are AHL lactonases, which use a dinculear zinc 
center to hydrolyze a wide range of AHL substrates (Figure 7).43 
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Figure 7. Potential Substrates and the AHL Lactonase-Catalyzed Reaction.  γ-Butyrolactone 
(GBL) and naturally-occurring and synthetic AHLs including C4-, C5-, C6-, C7-, C8-, 3-oxo-
C8-, C10-, C12-, cinnamoyl-, and t-BOC-HSL are assayed as potential AidC substrates.  The 
inset table assigns chain lengths in the neighboring structures to the matching abbreviations used 
throughout the text.   The general reaction catalyzed by AHL lactonases is also shown with C6-
HSL as an example, resulting in the C6-Hse and H+ products. 
      The gene encoding an AHL lactonase with unusual properties has been previously identified: 
aidC an autoinducer degrading gene isolated from a Chryseobacterium sp. strain StRB126 
originally associated with potato roots.19 The encoded protein, AidC (Genbank Protein: 
BAM28988; EC: 3.1.1.81), catalyzes the hydrolytic ring opening of multiple N-acyl homoserine 
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lactone (AHL) substrates.  Analysis of protein sequence alignments revealed that AidC is 
homologous to other AHL lactonases found in the metallo-hydrolase / oxidoreductase 
superfamily, and shares a conserved dinuclear metal binding motif.  However, AidC is 
phylogenetically distant from the other AHL lactonase clusters.19 For example, optimal global 
pairwise alignment44 of AidC with two other homologous dizinc AHL lactonases, AiiA 
(autoinducer inactivator A from Bacillus sp. 240B19) and AiiB (autoinducer inactivator B from 
Agrobacterium tumefaciens C5845) show only ~20% and ~17% amino acid identity, respectively.  
Additionally, these sequence alignments predict that active-site Asp and Tyr residues, conserved 
in other AHL lactonases due to their roles in zinc-binding and catalytic turnover, are possibly 
replaced in AidC by Leu and Ser, respectively.14,15,19 However, the most striking feature of AidC 
is its reported KM values.  All previously characterized wild-type AHL lactonases have KM 
values ≥ 1.4 mM11,15,46,with the exception of MomL (440 µM; Muricauda olearia marine AHL 
lactonase).47 In contrast, the reported KM values for AidC are approximately ≥ 24-fold lower: 46 
- 72 µM.19 The lower KM values of AidC are of interest since a better understanding of how 
quorum-quenching enzymes recognize and process their substrates can enable their appropriate 
selection and optimization as biochemical tools and help in the proposed development of this 
class of enzymes as therapeutic, anti-infective, and anti-biofouling proteins.39-42 Toward these 
ends, we report here the characterization of purified AidC alone, and with a bound product.  Two 
aspects of the active site are atypical compared to previously characterized AHL lactonases: a 
novel substrate-binding pocket defined, in part, by an unusual ‘kinked’ α-helix containing an 
internal proline residue, and an active site His substitution that is usually found in more distant 
superfamily members that belong to a different family, the phosphodiester hydrolases. 
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RESULTS AND DISCUSSION 
     Most AHL lactonases characterized to date have poor affinity for their substrates, as gauged 
by millimolar KM values.  However, unusually low micromolar KM values were reported for 
AidC-catalyzed hydrolysis of AHLs.19 To better understand the basis for substrate affinity, 
selectivity, and turnover in AidC, we cloned and purified this AHL lactonase for functional and 
structural studies. 
Purification of AidC, determination of activity and zinc content.   
    Heterologous expression of AidC in E. coli using a codon-optimized coding sequence (Figure 
8) led to good yields of purified protein (~ 10 mg / L culture).   
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Figure 8. Sequence of AidC.  Top lines shows the DNA sequence, codon optimized for 
expression in E. coli, that was obtained from commercial gene synthesis (IDT), and contained 
within a shuttle vector.  Bottom lines show the translated AidC protein sequence, including the 
N-terminal addition of a TEV protease cleavage site (ENLYFQ↓G, shown in blue).  The * 
indicates a stop codon. 
<Serial Cloner V2.5> -- <Jun 24, 2015   5:24 PM>
Restriction map of Ordered Seq AidC
Showing restriction enzymes cutting maximum 1 time [using RELibrary as a Restriction Enzyme Library]
###
               >TEV Cleavage Site       
               |
  gaa aac ctg tat ttt cag ggc ATG AAC CGG CGC GAG CTG CTG AAA AGC GGA CTG CTG GCG GGC ACT CTC TCA TTC ATG CCG  < 81
  E   N   L   Y   F   Q   G   M   N   R   R   E   L   L   K   S   G   L   L   A   G   T   L   S   F   M   P   
              10           20           30            40           50           60            70           80 
  
  TTC TCA AAC GTT TTC GCA GAA ACG AAA CTG TTC TCA GAG AAA ACC GAA GAT GAC CTC TCA GGG TTT AAG AAG ATT AAA CTT  < 162
  F   S   N   V   F   A   E   T   K   L   F   S   E   K   T   E   D   D   L   S   G   F   K   K   I   K   L   
             90           100          110          120           130          140          150           160 
  
  GGC GAG CTG GAA CTG TTT ATT CTG ACA GAT GGC TAC ATT CAC GAA GAG AAC TTA ATC AGT TTT GCC CCT CGC GGG AAT GTC  < 243
  G   E   L   E   L   F   I   L   T   D   G   Y   I   H   E   E   N   L   I   S   F   A   P   R   G   N   V   
           170          180           190          200          210           220          230          240 
  
  GCG GAA CTT AAA ACT ATT CTT AAA GAT AAC TTT CGT GCC GAC CAT TAC ATC GAC ATG GCG ATT AAC ATT CTT CTG GTG AAA  < 324
  A   E   L   K   T   I   L   K   D   N   F   R   A   D   H   Y   I   D   M   A   I   N   I   L   L   V   K   
          250          260          270           280          290          300           310          320 
  
  ACC AAG GAG AAA CTG ATT CTG ATG GAT ACC GGC ATG GGT ATC TTT GCA GAC GAG CGG ACC GGC TTT CTG TTG AAA TCA CTG  < 405
  T   K   E   K   L   I   L   M   D   T   G   M   G   I   F   A   D   E   R   T   G   F   L   L   K   S   L   
         330          340          350          360           370          380          390           400 
  
  CAG AAA GCC GGC TTT TCG GCA CAT GAT ATT ACC GAT ATT TTT TTA TCA CAT GCA CAT CCG GAT CAT ATT GGC GGT GTA GTA  < 486
  Q   K   A   G   F   S   A   H   D   I   T   D   I   F   L   S   H   A   H   P   D   H   I   G   G   V   V   
       410          420           430          440          450           460          470          480 
  
  GAC AAA CAG AAT AAG TTG GTC TTC CCG AAC GCG TCT ATT TTC ATC AGC AAA ATC GAG CAT GAT TTC TGG ATT AAT GCA AGC  < 567
  D   K   Q   N   K   L   V   F   P   N   A   S   I   F   I   S   K   I   E   H   D   F   W   I   N   A   S   
      490          500          510           520          530          540           550          560 
  
  ATT AAA GAC TTT AAC AAC AGT GCT CTG AAA GCC CAC CCG GAA CGT CTG AAC CAG ATC ATT CCA GCG CTG CAG AAC ATC CTG  < 648
  I   K   D   F   N   N   S   A   L   K   A   H   P   E   R   L   N   Q   I   I   P   A   L   Q   N   I   L   
     570          580          590          600           610          620          630           640 
  
  AAA GCC ATT CAA CCG AAA CTC AAG TTC TAT GAC CTT AAT AAA ACG CTG TAC TCC CAT TTC AAC TTC CAG CTG GCT CCA GGT  < 729
  K   A   I   Q   P   K   L   K   F   Y   D   L   N   K   T   L   Y   S   H   F   N   F   Q   L   A   P   G   
   650          660           670          680          690           700          710          720 
  
  CAC ACC CCT GGG CTG ACT GTT ACA ACT ATT AGC AGC GGC AAT GAA AAA CTT ATG TAT GTG GCA GAT TTG ATC CAT AGC GAT  < 810
  H   T   P   G   L   T   V   T   T   I   S   S   G   N   E   K   L   M   Y   V   A   D   L   I   H   S   D   
  730          740          750           760          770          780           790          800 
  
  GTA ATC CTG TTC CCA CAT CCG GAC TGG GGT TTC TCA GGT GAC ACA GAC TTA GAC ATT GCA ACG GCG AGT CGC AAA AAA TTT  < 891
  V   I   L   F   P   H   P   D   W   G   F   S   G   D   T   D   L   D   I   A   T   A   S   R   K   K   F   
              820          830          840           850          860          870           880          890 
  
  CTT AAG CAG CTG GCG GAT ACA AAG GCC CGT GCT TTC ACT TCA CAT CTG CCG TGG CCA GGC CTG GGC TTC ACC AAA GTA AAA  < 972
  L   K   Q   L   A   D   T   K   A   R   A   F   T   S   H   L   P   W   P   G   L   G   F   T   K   V   K   
             900          910          920          930           940          950          960           970 
  
  GCC CCG GGT TTC GAA TGG ATT CCC GAA AGC TTC ATG AAC TAA  < 1014
  A   P   G   F   E   W   I   P   E   S   F   M   N   *   
           980          990           1000         1010 
Features :
TEV Cleavage Site   : [1 : 21]
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     Kinetic characterization of the “as purified” form of untagged AidC gave KM (65 ± 4 µM) 
and kcat values (4.6 ± 0.1 s-1) for lactone hydrolysis of C6-HSL, similar to values reported 
previously for AidC containing an N-terminal maltose binding protein affinity tag: 55 ± 4 µM 
and 2.3 ± 0.2 s-1, respectively.19 Although we used a purification procedure similar to that for 
other AHL lactonases,48 we found that purified AidC does not contain the typical two 
equivalents of zinc ions.  Instead, the “as purified” AidC preparation only contained 1.2 ± 0.1 
equivalents of zinc ions per AidC monomer.  We suspected that the protein may not have fully 
retained its zinc content throughout the purification protocol, and so monitored the observed 
rates for AidC-mediated hydrolysis of saturating concentrations of substrate upon supplementing 
the Assay Buffer with varying concentrations of ZnSO4 (Figure 9).   
 
Figure 9. Optimization of Assay Zinc Concentration.  The relative observed initial rates of AidC-
catalyzed hydrolysis of C6-HSL under saturating conditions (1 mM) are graphed with respect to 
the concentrations of supplemental ZnSO4 added to the Assay Buffer.  Maximum activity was 
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detected at 30 µM supplemental ZnSO4.  Points are fitted to the equation: Activity (%) = 
Actmax×[Zn2+]/(EC50 + [Zn2+]×(1+[ Zn2+]/Ki)) where Actmax is the maximum activity, 
EC50 is the half maximal concentration of activation, and Ki is the apparent inhibition constant, 
with fitted values of 120 ± 10 %, 3.6 ± 0.9 µM and 300 ± 180 µM, respectively.   
      A significant increase in rate is observed upon increasing the ZnSO4 concentration, with a 
maximum activity at approximately 30 µM ZnSO4, and a slight decrease at higher 
concentrations.  Zinc supplementation leads to an increased kcat (C6-HSL: 59 ± 1 s-1), which is  > 
10-fold larger than the kcat of the “as purified” form.  If the 1.2 equivalents of zinc ions in the “as 
purified” AidC represent approximately half dizinc protein and half zinc-free protein, one might 
expect a two-fold increase in kcat values, at most, upon reconstitution of the dizinc active site.  
However, since the observed increase in rate is much larger, it likely represents instead an 
increase in activity due to the transition between mono- and dizinc metalloforms.  Further studies 
will be required to characterize zinc affinity in more detail.  However, a supplement of 30 µM 
ZnSO4 is used for the remaining kinetic experiments herein to maximize observed activity. 
Determination of kinetic parameters.   
     The previous characterization of AidC containing an N-terminal maltose-binding fusion 
protein reported unusually low KM values (C6-HSL: 55 µM, C8-HSL: 64 µM), with very little 
selectivity for, or against, related substrates with 3-oxo substitutions.19 The associated kcat values 
(approximately 2 s-1) are less than typically reported for AHL lactonases.  To augment this 
previous study, we determined the steady-state kinetic parameters for purified, untagged AidC, 
now supplemented with exogenous ZnSO4, using a broader set of substrates (Table 1).  
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Table 1.     Steady-State Kinetic Parameters for Substrates of Dizinc AidC 
Substrate KM   (µM) kcat  (s-1) kcat/KM (M-1 s-1) 
GBL N.D.a N.D. 16 ± 1 
C4-HSL 470 ± 60 39 ± 2 8.3 × 104 
C5-HSL 130 ± 20 57 ± 3 4.4 × 105 
C6-HSL 61 ± 4 59 ± 1 9.7 × 105 
C7-HSL 47 ± 5 80 ± 2 1.7 × 106 
C8-HSL 83 ± 10 45 ± 3 5.4 × 105 
C10-HSL 12 ± 4 5.2 ± 0.4 4.3 × 105 
C12-HSL 7 ± 4 0.40 ± 0.05 5.7 × 104 
3-oxo-C8-HSL 130 ± 20 28 ± 1 2.2 × 105 
cinnamoyl-HSL 470 ± 80 25 ± 2 5.3 × 104 
t-BOC-HSL 740 ± 70 44 ± 1 5.9 × 104 
    
a. N.D.: not determined.  The KM value for GBL exceeds 700 mM, so only the kcat/KM value was 
determined. 
      In general, we confirm the low KM values reported previously.  The KM values for zinc-
supplemented AidC, “as purified” AidC, and AidC with an N-terminal maltose binding fusion 
 26 
protein are all quite similar, independent of zinc content.  However, zinc supplementation (but 
not cleavage of the N-terminal tag) greatly improves the kcat values, which are all generally 
increased by > 20 fold.  These results indicate that the differences in kcat values between this and 
the prior report likely arise from differences in zinc content rather than the presence of the N-
terminal fusion protein.   
     As compared to other quorum-quenching enzymes, AidC appears to be a much more efficient 
catalyst.  If the kcat/KM value for hydrolysis of the best AHL substrate of AidC is compared with 
kcat/KM values for the best of the kinetically characterized substrates for other wild-type quorum-
quenching enzymes (including non-homologous enzymes from different superfamilies), AidC 
ranks the highest (Table 2).  Achieving the highest rank in this comparison is due to a 
combination of both a low KM value and a high kcat value, since AidC does not have the lowest or 
highest of either of these individual values with respect to the same set of enzyme/substrate pairs 
(Table 2).  Therefore, to the best of our knowledge, AidC appears to have the highest kcat/KM 
reported for any wild-type quorum-quenching enzyme to date.  Additionally, even when kcat/KM 
values are similar, the low KM value of AidC may make this enzyme more suitable than 
homologs with higher KM values for quorum-quenching applications at low AHL 
concentrations.49  
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Table 2.  Steady-State Rate Constants for Selected Wild-Type Quorum-Quenching Enzymes 
And AHL Substrates With Highest Reported kcat/KM Values 
Enzyme Substrate kcat 
(s-1) 
KM 
(µM) 
kcat/KM 
(M-1s-1) 
Reference 
AidC C7-HSL 80 47 106 This work 
MomL 3-oxo-C10-HSL 224 440 105 17 
PvdQa C12-HSL 2.5 11 105 50 
PON2b 3-oxo-C12-HSL 13 50 105 48 
PONX_OCCALc 3-oxo-C12-HSL 44 180 105 48 
AiiA C6-HSL 91 5600 104 14 
AiiB C6-HSL 25 1600 104 16 
MCPd C12-HSL 0.3 23 104 51 
VmoLace C8-HSL 0.6 260 103 52 
GKLf C8-HSL 0.5 1200 430 53 
a  Pyoverdine biosynthetic protein Q from Pseudomonas aeruginosa.  Enzyme belongs to the 
metal-independent NTN-hydrolase superfamily. 
b  Paraoxonase-2 from human.  Enzyme belongs to the dicalcium-binding paraoxonase family 
with a six-bladed β-propeller fold.    
c  Paraoxonase X from Oceanicaulis alexandrii.  Enzyme belongs to the same family as PON-2.  
d  Lactonase from Mycobacterium avium subsp. paratuberculosis K-10.  Enzyme belongs to the 
phosphotriesterase-like lactonase group of enzymes within the amidohydrolase superfamily. 
e  Lactonase from the hyperthermophile Vulcanisaeta moutnovskia.  Enzyme belongs to the same 
group as MCP. 
f  Lactonase from the thermophile Geobacillus kaustophilus.  Enzyme belongs to the same group 
as MCP. 
Substrate selectivity 
     As gauged by kcat/KM values, the most efficiently processed substrates of AidC are C6- and 
C7-HSL (approx 106 M-1s-1) (Table 1).  AHL substrates that differ in length by one methylene 
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have a > 2-fold decrease in their specificity constant (kcat/KM).  Commonly occurring AHLs 
with more extreme size differences, C4- and C12-HSL, are more significantly disfavored by 20- 
and 30-fold, respectively.  The previous characterization of AidC indicated no preference for or 
against 3-oxo substitutions,19 and here we find consistent results in which the 3-oxo substitution 
only mildly perturbs both KM and kcat values, resulting in a 2.5 fold decrease in kcat/KM.  The most 
significantly disfavored substrates we assayed were the bulky cinnamoyl-HSL50 and the 
synthetic t-BOC-HSL compound, which had specificity constants approximately 30-fold less 
than the best substrate.  Interestingly, the mechanism used to disfavor substrates with sterically 
bulky substituents appears to differ from that used to disfavor substrates with long unsubstituted 
n-alkyl substituents (see below).  
Structure determination and model building.  
      To better understand the structural basis of substrate recognition and catalysis, we 
determined the X-ray crystal structure of AidC, and the structure of AidC in complex with the 
reaction product C6-homoserine (C6-Hse) through co-crystallization with the substrate C6-HSL.  
Data processing and refinement statistics are shown in Table 3.  
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Table 3.  Crystallographic Data for AidC and AidC:C6-Hse complexes 
 AidC  AidC:C6-Hse 
PDB Code 4ZO2 4ZO3 
 Data Processing  
Space group P212121 P212121 
Cell dimension   
         α, β, γ (°) 90, 90, 90 90,90,90 
         a, b, c (Å) 51.7, 97.30, 110.64  47.09, 47.87, 249.15 
Resolution (Å) 1.09 1.67 
aRmerge (%) 4.9 (100)b 9.3 (75.4) 
I/σ (I) 23.6 (1.1) 20.3 (3.3) 
cCC1/2  
dRpim(%) 
0.997 (0.539) 
3.00 (60.8) 
0.992 (0.767) 
5.0 (41.8) 
Completeness (%) 99.6 (99.2) 99.3 (99.9) 
Multiplicity   6.6 (3.4)  4.4 (3.9) 
No. Reflections 1580815 295571 
No. Unique Reflections 239792 67109 
 Refinement  
Average B factor (Å2) 23.6 28.8 
eRwork/fRfree (%) 13.08/16.20 18.44/22.83 
No. of Atoms   
     Protein  4810 4714 
     Ligand N/Ag 30 
     Metal  4 4 
     Water 955 585 
B-factors   
     Protein  21.5 27.4 
     Ligand N/A 32.69 - 47.58 
gRMSD   
          Bond length (Å) 0.015 0.018 
          Bond angle (°) 1.401 1.164 
Ramachandran plot   
Most Favored (%) 97.70 97.29 
Allowed (%) 2.20 2.54 
Outliers (%) 0.00 0.17 
a Rmerge = Σ|Iobs-Iavg|/ ΣIavg 
b The values for the highest resolution bin are in parentheses. 
c CC1/2, Pearson correlation coefficient of two “half” data sets. 
d Rpim, the precision-indicating merging R 
e Rwork = Σ|Fobs-Fcalc|/ ΣFobs 
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f Five percent of the reflection data were selected at random as a test set and only these data were used to              
calculate Rfree. 
g RMSD, root mean square deviation; N/A, Not Applicable 
 
      The unliganded AidC crystal diffracted to a resolution of 1.09 Å. The 2Fo-Fc omit map for 
the active site zinc ions and coordinating residues is shown in Figure 10.  The “substrate-treated” 
AidC co-crystal diffracted to a resolution of 1.67 Å and contained the ring-opened product, C6-
Hse.  The final Rwork/Rfree values for AidC and AidC:C6-Hse are 13.08 / 16.20 % and 18.23 / 
23.07 %, respectively.  The occupancies of the zinc ions are refined to values between 0.6 and 
0.8, as assessed by occupancy refinement in Phenix.  During crystallization, the concentration of 
enzyme is higher, and the solution pH values lower, than during the functional studies discussed 
above.  So, these occupancies may not reflect zinc binding during kinetic studies, and will be a 
topic for future experiments. 
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Figure 10.  2Fo-Fc omit map for the unliganded AidC dizinc site and coordinating residues.  
The map is shown at two different σ levels, with the grey mesh at 1.5 σ and the magenta mesh at 
4.0 σ.  The protein and zinc atoms are shown in ball-and-stick form, and colored with tan for 
carbon, blue for nitrogen, red for oxygen and grey for zinc.  The 4σ map can be seen to indicate 
individual atom positions, characteristic of an ultra high resolution map. 
AidC core structure, ‘kinked’ helix and dimerization 
     The AidC monomer structure displays a characteristic pseudosymmetrical core of two mixed 
β-sheets flanked by α-helixes to form the αββα protein fold conserved throughout the entire 
metallo-hydrolase / oxidoreductase superfamily, as cataloged in the Structural Classifications of 
Proteins (SCOP) database.51 A dinuclear zinc ion cluster is found at one edge of where the two 
central β-sheets meet and is described below in more detail as part of the active site.  A structural 
overlay of AidC with two related AHL lactonases, AiiA13 and AiiB46, highlights their conserved 
αββα cores, and shows the most significant structural divergence occurs in loops and helixes, 
adjacent to the dizinc active site, which serve to connect the core secondary structural elements 
(Figure 11A).  Parts of these regions interact closely with active-site ligands. 
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Figure 11. Structure of AidC Monomer.  A. Superimposition of AidC (blue), AiiA (pink), and 
AiiB (green) structural models.  Proteins backbones are depicted as ‘licorice’ strands. Structural 
conservation is higher in the zinc-binding site and the αββα core scaffold of the protein, but 
diverges more significantly in the connecting elements surrounding the active site.  B.  Ribbon 
diagram of a ‘kinked’ α-helix in AidC containing an internal proline residue.  The regular H-
bonding pattern (in black thin lines) of the α-helix backbone from residues P195 – A211 is 
interrupted by an internal P203 residue.  The two ends of the α-helix, defined as P195-Q200 
(blue) and A204-A211 (green) are offset by approximately 25°.  Hydrophobic side chains near 
the bend, I201and L198 (surface in grey), contribute to the binding site for the N-acyl substituent 
of the bound product (C6-Hse, shown in space-fill form).    
 33 
     The AidC structure contains an unusual feature.  One of the major helices H11 containing 
residues P195-A211 has an internal proline residue (P203) that disrupts the regular H-bonding of 
the α-helix.  It results in a ‘kinked’ structure where one segment of the α-helix is found at an 
approximate 25° angle from the other (Figure 11B).  Most soluble proteins do not contain α-
helixes with internal proline residues, but this feature is not unprecedented.52 A survey of 291 
helices found that approximately 3% contain an internal proline, and the associated helix ‘kinks’ 
typically measure 26° ± 5°, tilting away from the proline sidechain, consistent with what is found 
in AidC.53 Kinked α-helices typically place the hydrophobic side chain of the internal proline 
residue toward the solvent, and the kink aids in packing long helices around globular proteins;54 
both of these attributes are observed in AidC.  Proline residues responsible for inducing kinks are 
typically highly conserved,53 but P203 is not a conserved residue in this superfamily.  However, 
several side chains of residues near the P203-induced kink do form part of the AidC substrate-
binding cavity, suggesting a functional implication for this unusual structural element. 
     In our structural determination, AidC displays as a crystallographic dimer in the spacegroup 
P212121 (Figure 12A).  The protein-protein interface is heterogeneous and comprised of 
hydrophobic interactions as well as direct and through-water hydrogen bonds.  The Proteins 
Interfaces Structures and Assemblies (PISA) algorithm55 was used to calculate 2440 Å2 buried 
surface area, and predicts a ΔGdiss of 6.1 kcal / mol.   
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Figure 12.  The Dimer Structure of AidC and Homologs. Each monomer is shown in ribbon 
form, with rainbow coloring from each N-terminus (blue) to the corresponding C-terminus (red).  
Rainbow coloring is used here to facilitate chain tracing and to emphasize similarities and 
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differences between the oligomeric interfaces.  Zinc ions are shown as grey spheres.  A.  
Depiction of the AidC dimer.  B.  Depiction of the OPHC2 dimer (from PDB: 4LE6).  C. 
Depiction of the AiiB dimer (from PDB: 2R2D).  The dimers of AidC and OPHC2 are very 
similar, but that of AiiB is divergent and uses different protein-protein interfaces 
      To determine if oligomerization is relevant in solution, size-exclusion chromatography – 
multiple angle light scattering (SEC-MALS) was used to assay for AidC oligomers (Figure 13).  
First, AiiA was used as a control since this homologous AHL lactonase was previously shown by 
analytical ultracentrifugation to be monomeric in solution.13 Purified AiiA elutes from the size 
exclusion column as a single peak (detected by Abs280 nm), and light scattering is used to 
determine a molecular weight of 28 ± 2 kDa for this peak, which matches the mass calculated 
from the expected sequence (28,635 Da).  Purified AidC elutes from the size exclusion column 
as one major peak preceded by a small second peak.  The molecular weight determined for the 
major peak, 72.1 ± 0.9 kDa, matches reasonably well with that calculated for the dimer (36979 × 
2 = 73,958 kDa).  The molecular weight calculated for AidC oligomers in the small minor peak 
is 148 ± 4 kDa, which matches that calculated for the tetramer (36979 × 4 = 147,916 kDa).  
Therefore, at least when high protein concentrations are used, AidC forms a dimer in solution.  
Further studies will be required to determine if the dimer interface observed crystallographically 
is conserved in solution.  Under the dilute assay conditions used to determine steady-state kinetic 
parameters, the activity of the enzyme varies linearly with concentration (Figure 14).  So, either 
the dimer Kd value does not occur within the tested concentration range, or there is no change in 
activity upon change in oligomeric state.     
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Figure 13.  Molecular Weight Determinations of AidC and AiiA in Solution.  SEC-MALS 
profiles are shown for AiiA and AidC.  Absorbance at 280 nm is shown as a black line and 
calculated molecular weight for protein in the eluent at a particular time is shown in color, as 
noted. A) AiiA (molecular weight in red) gives a single peak with a molecular weight of 28 ± 2 
kDa.  B).  AidC gives two peaks with the major peak containing an oligomer with the molecular 
weight (in red) of 72.1 ± 0.9 Da, and a minor preceding shoulder containing an oligomer with the 
molecular weight (in blue) of 148 ± 8 Da. 
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Figure 14 .   Correlation of observed rate with enzyme concentration.  The relative rates of AidC-
catalyzed hydrolysis of t-BOC-HSL (5 mM) at varying concentrations of “as purified” AidC, 
with Assay Buffer supplemented with ZnSO4 (30 µM).  AidC concentrations are those calculated 
using the monomer molecular weight 
      Previously, various AHL lactonases have been characterized as monomers13 and dimers,46 
and the superfamily has examples of higher oligomers.  When the AidC dimer structure is 
compared with that of AiiB (Figure 12C), which has been observed as a dimer in a crystal,46 and 
in solution (unpublished observations), it is clear that the protein-protein interfaces are actually 
very divergent and involve different sides of the protein.  However, when the AidC dimer 
structure is compared to the crystallographic dimer structure of the organophosphotriesterase 
OPHC2 (Figure 12B),56 the protein-protein interfaces that comprise each dimer interface appear 
to be structurally conserved.  In fact, the overall structural similarity of AidC ranked higher with 
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OPHC2 than with any other AHL lactonase, as gauged by the Dali server for structural 
comparison of proteins.57 The active sites for each AidC monomer are distant from each other, 
and none of the structural or functional evidence presented here suggests that they are 
interdependent.  Interestingly, AidC appears to also conserve other features besides this 
dimerization interface, with superfamily members outside of the immediate AHL lactonase 
family as will be described below.  
 AidC active site 
     The dinculear zinc active site of AidC is highly conserved with other AHL lactonases and 
other members in the superfamily.  As can be seen in the comparison of dinuclear zinc sites in 
AidC, the AHL lactonase AiiA,13 the organic phosphotriesterase OPHC2,56 and the 
phosphodiesterase ZipD,38 all the zinc-1 (Zn1) ions are coordinated by three histidines, and all 
the zinc-2 (Zn2) ions by two histidines and an aspartate, with both zinc ions sharing a 
monodentate bridge by an aspartate residue and most sharing a bridging water.  Although a 
bridging water is not modeled into the ZipD structure, its presence may be obscured by the 
resolution of the diffraction (2.9 Å).   Due to its proximity to both zinc ions, this conserved 
bridging water is likely bound as a hydroxide ion, which is proposed to be the hydrolytic 
nucleophile (Figure 15),43 similar to its function in other superfamily members.58 The Zn1 and 
Zn2 of AidC also each coordinate to their own apical water molecules, illustrating the proposed 
coordination sites for the lactone carbonyl oxygen and ring oxygen in AHL substrates, 
respectively.  In all cases, the Zn-to-Zn distances are all very similar (see Figure 15 legend for 
relevant distances).   
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     There is one notable difference in AidC immediately adjacent to the dinculear zinc cluster.  
All of the AHL lactonases previously characterized have a Tyr (Y194 in AiiA; Figure 15B) that 
we previously proposed as a H-bond donor to help stabilize a tetrahedral adduct formed in the 
hydrolysis reaction.43 However, this position in AidC is instead occupied by His261 (Figure 
15A).  Although, the related organic phosphotriesterase OPHC2 has a Leu at this position 
(Figure 15C), and likely does not use this residue during catalysis, the homologous 
phosphodiesterase ZipD does places a His side chain in the same structural position (Figure 
15D), with the residue coming from a position later in the primary sequence.  
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Figure 15.  Unliganded Active-Site Structures. A.  Active-site structure of AidC (blue). Protein 
residues are shown as sticks, and zinc ions (grey) and water molecules (red) as spheres, with 
oxygens in red and nitrogens in blue.  The Zn-to-Zn distance is 3.3 Å; the Zn-O distances to the 
bridging hydroxide are 1.9 and 2.0 Å; The distance from Zn1 to its apical water is 2.7 Å, and 
Zn2 to its apical water is 2.5 Å; The distance from the bridging hydroxide to the non-chelating O 
of D149 is 2.7 Å; and the distance from His261 εN to the Zn1 and Zn2 apical waters is 3.4 and 
3.0 Å, respectively.  B.  Active site structure of AiiA (green, from PDB: 2A7M).  The Zn-to-Zn 
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distance is 3.3 Å; The Zn-O distances to the bridging hydroxide are 2.1 and 2.0 Å; and the 
distance from the bridging hydroxide to the non-chelating O of D108 is 2.8 Å.  C.  Active site 
structure of OPHC2 (pink, from PDB: 4LE6).  The Zn-to-Zn distance is 3.2 Å; The Zn-O 
distances to the bridging hydroxide are both 2.2 Å; and the distance from the bridging hydroxide 
to the non-chelating O of D143 is 2.7 Å.  D.  Active site structure of ZipD (grey, from PDB: 
2CBN).  The Zn-to-Zn distance is 3.3 Å.  No bridging or apical waters were modeled into the 
structure, possibly due to the limited diffraction resolution (2.9 Å).     
     Our determination of the AidC structure allows a structural alignment to be constructed that 
helps to correct some prior predictions based on primary sequence alignments (Figure 16).  
Leu259 was predicted to replace the zinc-bridging Asp residue,19 but Asp258 is seen here to 
retain this role.  Also Ser262 was predicted to replace the Tyr adjacent to the active site, but, as 
discussed above,19 the His261 side chain is shown to occupy this position. 
A  
AidC L E L F I L T D . . . . . . . . . . G Y I H E E N L I S F A . . . P R . G . N . . . . . . . . . . .50   73
AiiA K K L Y F I P A . . . . . . . . . . G R C M L . D H . . . S S V N . S . A L T P . . . . . . . . . .4   27
AiiB N K L F V L D L . . . . . . . . . . G E I R V . D E . . . N F I I . A . N S T . F V T P Q K P T V S3   35
OPHC2 F E V T A L Y D . . . . . . . . . . G Y V D L . P A S L . L . . . . K G I . D . . . . . . . . . . .45   66
TRNaseZ M E L L F L G T G A G I P A . K A R N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1   18
ZipD M N L I F L G T S A G V P T R T . R N . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1   18
AidC V A E L K T I L K D N F R A D H . . Y I D M A I N I L L V K T . . K . . E . K L I L M D T G M G . I74   115
AiiA G . . . . . . . . . . . . . . K . . L L N L P V W C Y L L E T . . E . . E . G P I L V D T G M P . E28   55
AiiB S . . . . . . . . . . . . . . R . . L I D I P V S A Y L I Q C . . T . . D . A T V L Y D T G C H P E36   64
OPHC2 D K D L Q S L L A R M F V A . S E K G V Q T A V N A Y L I N T . . G . . D . N L V L I D T G A A . Q67   109
TRNaseZ . . . . . . . . . . . . . . . . . . . . . . . V T S V A L K L L E E . . R R S V W L F D C G . E . .19   40
ZipD . . . . . . . . . . . . . . . . . . . . . . . V T A I L L N L . Q H P T Q S G L W L F D C G . E . .19   41
AidC F A . . D . . . . . . . . . . . . . . . . . . . . . . . E R T G . . . . . F . L L K S L . Q K A G F116   133
AiiA S A V N N E G . . . . . L F N G T F V E . . . G Q I L P . K M . . T E E . D R I V N I L . K R . V G56   91
AiiB . C . . M . . G T N G R W P A . . . . Q S Q L N . A P Y . I G . A S . E C N . L P E R L . R Q . L G65   98
OPHC2 C F . . G . . . . . . . . . . . . . . . . . . . . . . . P T L G . . . . . V . V Q T N L . K A S G Y110   127
TRNaseZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . T Q H Q M . L H T T I41   51
ZipD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G . T Q H Q L L H T . A F42   52
AidC S A . H D I T D I F L S H A H P D H I G G V V D K . Q N K L V F . . P . . . . . . . N A S I F I S K134   172
AiiA Y E P D D L L Y I I S S H L H F D H A G G N G . . . . . . . A F . . T . . . . . . . N T P I I V Q R92   125
AiiB L S P D D I S T V V L S H L H N D H A G C V E . . . . . . . Y F . . G . . . . . . . K S R L I A H E99   132
OPHC2 Q P . E Q V D T V L L T H L H P D H A C G L V N A D G . S P A Y . . P . . . . . . . N A T V E V P Q128   166
TRNaseZ K P . R K I E K I F I T H M H G D H V Y G L P G . . . . . . L L G S R S F Q G G E D E L T V Y G P .52   93
ZipD N P . G K L D K I F I S H L H G D H L F G L P G . . . . . . L L C S R S M S G I I Q P L T I Y G P Q53   95
Conservation  : :   :             .                                
Consensus m e L f f L g d . . . . . . . . . . g . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Conservation                        :     : :            *  *  *     
Consensus . . . . . . . . . . . . . . . . . . . . . . . V t a y L l k t . . e . . e . g l i L f D t G . e . .
Conservation                                            :       
Consensus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . a . l q h q L . k a . g g
Conservation     . :   : .  : *  *  * *                            :     
Consensus k p . d d i d k i f l s H l H p D H a g G l p . . . . . . . a f . . p . . . . . . . n a t i i g p q
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Figure 16.  Structure-Based Sequence Alignment of AHL lactonases and Homlogs: AidC, AiiA, 
AiiB, OPHC2, tRNAseZ, and ZipD.  The structural models of AidC, AiiA (PDB: 2A7M), AiiB 
(PDB: 2R2D), OPHC2 (PDB: 4LE6), tRNaseZ (PDB: 1Y44), and ZipD (PDB: 2CBN) are 
superimposed and a structure-based sequence alignment calculated using the program UCSF 
Chimera (Pettersen, EF, Goddard, TD, Huang, CC, Couch, GS, Greenblatt, DM, Meng, EC, 
Ferrin, TE. UCSF Chimera: A visualization system for exploratory research and analysis. J. 
Comput. Chem. 2004, 25, 1605-1612).  Only three separate regions of the entire alignment have 
AidC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . . L Y S H . F N F Q L224   233
AiiA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E . V V P G . V Q L L Y156   165
AiiB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R E L A P G V N L L N F176   187
OPHC2 G M Q G M F K M A Q Q A V A P Y A K M N K L K P Y K T E G E L . . . . . . . . . L . P G . V S L V A184   222
TRNaseZ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V F E D D Q F I V . . . . . . . T A V S125   137
ZipD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I L D D . G L . . . . . R K . V T A Y P126   138
AidC A P G H . T P G L T V T T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .234   245
AiiA T P G H . S P G H Q S L F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .166   177
AiiB G T G H . A S G M L G L A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .188   199
OPHC2 S P G H . T P G H T S Y L . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .223   234
TRNaseZ V . I H G V . E A F G Y R V Q E K D V P G S L K A D V L K E M N I P P G P V Y Q K I K K G E T V T L138   185
ZipD L . E H P L . E C Y G Y R I E E H D . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .139   154
Conservation                                                   
Consensus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . l . p g . v t l v a
Conservation    *                                               
Consensus a p g H . t p g h t g y r . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Conservation
AidC . . . . . . . . . . . . . . . . . I S S G . . N E K L M Y V A D L . I . . . . . . . . . . . . . . .246   260
AiiA . . . . . . . . . . . . . . . . . I E T E Q S . G S V L L T I D A S Y . . . . . . . . . . . . . . .178   194
AiiB . . . . . . . . . . . . . . . . . V R L E K Q . P G F L L V S D A C Y . . . . . . . . . . . . . . .200   216
OPHC2 . . . . . . . . . . . . . . . . . F K S G . . G Q S L L V W G D I . L . . . . . . . . . . . . . . .235   249
TRNaseZ . . . . . . . . . . . . . K G R S V . . . . . . . . . V F S G D T R . V S D K L K E L A . R D C D V202   227
ZipD R Q I N G A D Y L A A P V P . G . . . K . . . . . A L A I F G D T G . P C D A A L D . L A K G V D V190   228
AidC . . . . . H S D V . . I . . L F P H . . . . . P D W . . . G F S G D T D L D I . A T A . S R K K . F261   290
AiiA . . . . . T . K . . . . . . . E . N F E . D E V . . . . P F A . . G F D . P E L A . L S S I . K R L195   220
AiiB . . . . . T . A . . . . . . . T . N Y G P P A R . . . . R A G V . L H D . T I G Y . D R T V . S H I217   244
OPHC2 . . . . . L N H A . . V . . Q F A K . . . . . P E V . . . V F E F D V D S D Q . A R Q . S R Q R . I250   279
TRNaseZ M V H E A T . F A K E D . . . . . R . . . . . . . K L A Y D Y . . Y . . . . . . . . . . . . . . . .228   246
ZipD M V H E A T L . D . . I T M E . . . . . . . . . . A K A N S R . . G . . . . . . . . . . . . . . . .229   247
AidC . . . . . . . . . L K . Q . L . A D T . . K . . A . R A F T S H L P . . . . . . . . . . . . . . W P291   309
AiiA . . . . . . . . . . . . K . E V V . K K E K . . P . I I F F G H D I . . . . . . . . . . . . E Q E K221   241
AiiB . . . . . . . . . . . . R . Q Y A . E S R . S . L . T V L F G H D R . . . . . . . . . . . . E Q F A245   265
OPHC2 . . . . . . . . . L A . E . A . A T D . . K . . L . W V A G A H L P . . . . . . . . . . . . . . F P280   298
TRNaseZ H S T . . . T . E Q A A . V T . A K E A . R A K Q . L I L T . H I S . A . R . . . Y Q G D A . . . S247   279
ZipD H S S T R Q A A T . L A . . . . R E A . . G V . G K L I I T . H . V S S R Y D D K G C . Q H L . . L248   284
Conservation                                *                   
Consensus . . . . . . . . . . . . . . . . . i . s . . . . . s l l l v g D a . . . . . . . . . . . . . . . . .
Conservation                                                   
Consensus . . . . . t . . . . . . . . . . . n . . . . . . . . . . . a f . . d . d . . . . a . . . s . . . . .
Conservation                                *                   
Consensus . . . . . . . . . . . . . . . . a . e . . k . . l . l i l t . H l p . . . . . . . . . . . . . . . p
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significant structural overlap, and are presented above as A, B and C, with the fully populated 
columns highlighted in yellow.  Primary references for the PDB entries are as follows:  AidC 
(this work); AiiA (2A7M); AiiB (2R2D); OPHC2 (4LE6); tRNaseZ (1Y44); and ZipD (2CBN).  
AidC product complex   
     Addition of the substrate C6-HSL to the crystallization mixture allowed us to characterize the 
interactions of product with the AidC active site (Figure 17A).  Although technically this 
experiment could be classified as co-crystallization, the substrate and enzyme were incubated 
together for three days before the mixture was “seeded” with unliganded AidC crystals.  
Therefore this procedure may be more akin to co-crystallization with product, or if the 
unliganded AidC seeding biases the resulting conformation, crystal soaking with the product.  
Regardless, the experiment resulted in a structure in which product was bound at the active site 
of AidC.   
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Figure 17. C6-Hse Product Bound Structure of AidC. A. Active site of AidC bound to product 
C6-Hse. Carbon atoms are in light blue, oxygen in red, nitrogen in dark blue, and zinc in grey. 
The green dotted line represents the hydrogen bonds formed between the C6-Hse and AidC. Zn-
Zn distance is shown as a grey dotted line. B. Simulated Annealing Omit Map (Fo-Fc) for 
Product.  The omit map is shown as a grey mesh at 2.2 σ.  The omit map was generated with 
both the C6-Hse and bridging hydroxide omitted from the coordinates.  Carbon atoms are in light 
blue, oxygen in red, nitrogen in dark blue, and zinc in grey. 
     The simulated annealing omit map (Fo-Fc) electron density found at the active site of AidC 
monomer A is very well defined and matches with the ring-opened product C6-Hse (Figure 17 
B).  The density at the same relative position in monomer B is also consistent with fitting C6-
Hse, but is less well defined.   The newly-formed product carboxylate coordinates both zinc ions, 
bridging the site in a bidentate fashion (A).  The positioning of the amide and alcohol 
substituents are generally similar to that seen in the product complex with the homologous AHL 
lactonase AiiA (Figure 17),14 however there are some differences.  In AidC, the product 
carboxylate oxygens are farther from the zinc ions (~ 2.5 Å) than those in product-bound AiiA (~ 
2.1 Å).  Also, the AidC product complex has a closer Zn-to-Zn distance (3.2 Å) and retains a 
bridging hydroxide, but the AiiA product complex has a longer Zn-to-Zn distance (3.7 Å) and is 
missing the bridging hydroxide.  If AidC and AiiA use the same catalytic mechanism, these two 
structures may represent different steps along the reaction coordinate.  The AiiA structure shows 
that the product closely associates with the zinc ions after ring opening, and the AidC structure 
may illustrate how the product is then displaced by reforming the hydroxide bridge, reducing the 
Zn-to-Zn distance and lengthening the bonds between the product and the zinc ions.  The 
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product-bound AidC complex may also shed light on the relative positioning of substrate at 
the active site.  The bridging hydroxide is only 2.6 Å from the carbonyl carbon of the product; 
this close positioning may mimic the substrate bound complex in which hydroxide attacks this 
substrate carbonyl.  However, the –OH-C4-O2 angle is only 78°, so the product is likely angled 
differently than substrate, for which a larger, more typical Bürgi-Dunitz angle59 would be 
predicted. 
 
Figure 18. Product-Bound Active-Site Structures.  In all cases the liganded product is shown as 
ball and stick, and the binding site consisting of protein residues is shown as sticks, with 
heteroatom coloring as above.  A.  Active-site structure of AidC bound to C6-Hse (blue).  
Measurements are given for monomer A.  The Zn-to-Zn distance is 3.3 Å; the Zn-O distances to 
product are each 2.5 Å, and the Zn-O distances to the bridging hydroxide are each 2.0 Å.  The 
H261 Nε is 3.6 and 2.7 Å from the product carboxylate oxygens.  B.  Active site structure of 
AiiA bound to product (green, from 3DHB).  The Zn-to-Zn distance is 3.7 Å; the Zn-O distances 
to product are 2.0 and 2.1 Å; and the distance of the leaving group alcohol to the closest O of the 
unchelated conformer of D108 is 2.6 Å.  The Y194 phenol O is 3.8 and 4.0 Å from the product 
carboxylate oxygens.  C.  Active site structure of tRNase Z bound to phosphate (grey, from 
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1Y44).  tRNase Z and ZipD (Figure 15D) are different proteins, but both are colored grey to 
indicate that they are both phosphodiesterases.  The Zn-to-Zn distance is 3.3 Å; the Zn-O 
distances to the bridging hydroxide are 2.0 and 2.3 Å; the Zn-O distances to product are 2.3 and 
2.5 Å; the distance from the closest O of D67 and PO42- is 3.6 Å, and the other non-chelating O 
of PO42- is 3.1 Å from the Nε of His247. 
     One particular amino acid substitution raises the possibility that the AidC mechanism might 
diverge from that of AiiA.  In AiiA, the Y194 residue was proposed to help stabilize the 
tetrahedral adduct formed upon initial hydroxide attack.15 However the H261 residue in AidC, 
which occupies the same relative position, has a lower predicted pKa value.  Additionally, the 
H261 Nε is more distant (3.6 Å) from the product oxygen that is placed where the carbonyl of the 
substrate is predicted to occupy than it is to the product oxygen that placed where the leaving 
group of the substrate is predicted to occupy (2.7 Å).  This arrangement suggests a possible 
participation in ring opening through general acid / base catalysis, a mechanism reminiscent of 
that proposed for the homologous phosphodiesterase tRNAse Z in which a structurally conserved 
histidine is proposed to act as a general acid during hydrolysis.60 In the phosphate bound 
structure of tRNAse Z, the structurally analogous histidine (His247) can be seen within H-
bonding distance (3.1 Å) to one of the phosphate oxygens (Figure 18C).61 (Since a product-
bound ZipD structure is not available, we consider instead the homologous phosphodiesterase 
tRNAse Z, which also contains this active-site His substitution.)  Further studies will be required 
to see if AidC uses His261 as a mimic of Y194 in AiiA, or if it instead uses this residue for 
general acid / base catalysis or a different function.   
The N-alkyl substituent binding pocket and a mechanism for selectivity   
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      The most striking difference between the product-bound AidC and AiiA structures are the 
binding pockets for the N-acyl substituents of the products (Figure 19).  AidC contains a 
hydrophobic pocket, formed in part by the ‘kinked’ α-helix that completely surrounds the 
terminal part of the N-acyl substituent, which is buried below the surface of the protein (Figure 
19A, 20B, 11B).  In contrast, AiiA instead only cradles the N-acyl substituent of C6-Hse along a 
wide and shallow hydrophobic trough found on the surface of the enzyme (Figure 19C, 20D).14 
Products with longer N-acyl substituents can also bind to AiiA in an alternative orientation (not 
shown) in which they receive some additional stabilization by a “phenylalanine-clamp.”16 
However, in contrast to the relatively open N-acyl binding site in AiiA, AidC instead contains a 
closed, well-defined N-acyl binding pocket that is unlike the substrate binding pockets in all 
previously characterized AHL lactonases in the superfamily, and this pocket is likely the major 
contributor to the uniquely low KM values observed for substrates of this enzyme. 
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Figure 19. N-Acyl Chain Binding Pockets.  A.  A surface coated AidC (blue) is shown with the 
C6-Hse product as ball and stick (carbons in grey, heteroatoms as above).  The N-acyl chain of 
the product is buried below the surface.  B.  A rotated, cut-away view of Figure 19A, showing a 
defined pocket for binding the N-acyl chain of the product, while the opened ring is pointing 
toward solvent.  C.  A surface coated AiiA (green, from PDB: 3DHB) is shown with the C6-Hse 
product as ball and stick (coloring as above).  The N-acyl chain lies in a shallow groove of the 
enzyme and is visible from the surface.  D.  A rotated, cut-away view of Figure 19C, showing the 
N-acyl chain of the product extending toward the solvent and the opened ring enclosed in a more 
defined pocket.   
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     This binding pocket suggests a mechanism whereby AidC can impose substrate selectivity.  
Substrates with short N-acyl substituents would not be able to reach as deeply into the pocket and 
bury as much hydrophobic surface as longer, more favored substrates, and a resulting difference 
in KM values would ensue.  For example C4-HSL has a 10-fold higher KM value than C7-HSL, 
but the differences in kcat values are more minor.  The same effect is seen with substrates 
containing very bulky N-acyl substituents that can not easily enter the buried pocket, such as 
cinnamoyl- and t-BOC-HSL, which have KM values 10- and 16-fold higher than C7-HSL, again 
with lesser effects on kcat values.  In contrast, substrates with longer N-acyl substituents would be 
disfavored by a different mechanism.  The long alkyl substitutions on these substrates could 
easily enter and fully occupy the binding pocket, but as the length of this substituent increases, 
the attached lactone group would be held farther away from the catalytic dinuclear zinc center, 
for which a difference in kcat values would be predicted.  For example, C12-HSL actually has a 
7-fold lower KM value than C7-HSL, but catalysis is more significantly impaired, as seen in the 
200-fold lower kcat value.  This selectivity mechanism is different than that used by other AHL 
lactonases characterized to date.  However, we have shown that the nonhomologous, metal-
independent N-terminal nucleophile hydrolase PvdQ uses a similar strategy to discriminate 
between N-acyl-HSL substrates of different lengths.62  
CONCLUSIONS 
     The quorum-quenching AHL lactonase from the potato root-associated Chryseobacterium sp. 
strain StRB126, AidC, has an unusually low KM value for AHL substrates and displays a stricter 
substrate selectivity than any other related AHL lactonase characterized to date.  At the time of 
writing, AidC also has the highest reported kcat/KM value for any characterized wild-type 
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quorum-quenching enzyme, regardless of superfamily.  Structural determination of AidC 
alone, and with bound product, reveals an unusual ‘kinked’ helix and suggests a structural-basis 
for the enhanced selectivity.  Further studies will be required to determine how and if this 
selectivity impacts the chemical ecology of Chryseobacterium sp., but we note that Erwinia 
carotovora, a phytopathogen relevant to potatoes, produces AHLs within the optimal range for 
AidC substrates63, and that AHL lactonases have been shown to impact rhizosphere 
competence.64 Intriguingly, AidC shows some structural similarities that more closely match 
families more distant from AHL lactonases, sharing a dimeric structure similar to an organic 
phosphotriesterase and an active-site histidine residue similar to that found in related 
phosphodiesterases.  Tawfik and co-workers have identified an entirely different superfamily in 
which both paraoxonase and lactonase activities have evolved,65–67 and may, by comparison, 
provide insight into the relationship of the various activities found in AHL lactonase homologs.  
AidC serves as an example for understanding how quorum-quenching enzymes can achieve 
selectivity between structurally similar AHL substrates, and may serve as an efficient catalytic 
template amenable to further optimization for a broad array of quorum-quenching applications.    
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MATERIALS AND METHODS 
Materials  
     Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich Chemical Co. (St. 
Louis, MO), and all enzymes used for cloning were purchased from New England BioLabs 
(Beverly, MA).  The lactones assayed as substrates, γ-butyrolactone (GBL) and tert-
butyl(tetrahydro-2-oxo-3-furanyl)carbamate (t-BOC-HSL), were purchased from Sigma-Aldrich 
Chemical Co. (St. Louis, MO).  N-Butyryl-L-homoserine lactone (C4-HSL) and N-3-oxo-
octanoyl-L-homoserine lactone (3-oxo-C8-HSL) were from Cayman Chemical Co. (Ann Arbor, 
MI).  N-Pentanoyl-(S)-homoserine lactone (C5-HSL), N-hexanoyl-(S)-homoserine lactone (C6-
HSL), N-heptanoyl-(S)-homoserine lactone (C7-HSL), N-octanoyl-(S)-homoserine lactone (C8-
HSL), N-decanoyl-(S)-homoserine lactone (C10-HSL), N-dodecanoyl-(S)-homoserine lactone 
(C12-HSL), and N-cinnamoyl-(S)-HSL (C-HSL) were synthesized from (S)-α-amino-γ-
butyrolactone hydrochloride and the corresponding acyl chloride similar to the methods 
described previously.15,18 Substrate stock solutions were prepared in methanol, with the final 
assay mixtures containing 1% methanol cosolvent.   
Cloning, expression and purification of AidC 
     The coding sequence for AidC from Chryseobacterium sp. Strain StRB126, was codon 
optimized for expression in Escherichia coli; a sequence encoding the cleavage site for tobacco 
etch virus (TEV) protease (ENLYFQG) was inserted at the 5’ end of the AidC coding region; 
restriction sites EcoR1 and Nde1 were added to the 5’ and 3’ ends, respectively; and the resulting 
sequence was ordered from Integrated DNA Technologies, Inc. (Figure 8).  A shuttle vector 
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carrying the synthesized gene and a commercial protein expression vector, pMAL-C5X (New 
England Biolabs, Beverly, MA), were both digested using restriction enzymes EcoR1 and Nde1, 
and the resulting insert containing aidC was ligated into the expression vector using T4 DNA 
Ligase (New England Biolabs, Beverly, MA) to yield a protein expression plasmid encoding an 
N-terminal maltose binding protein (MBP) linked through a TEV cleavage sequence to the full 
length AidC enzyme.  The resulting vector (pMAL-t-AidC) was used to transform E.coli DH5α 
cells for plasmid storage and amplification.  The entire coding region in pMAL-t-AidC was 
verified by DNA sequencing to determine that there were no unintended mutations (CRC DNA 
Sequencing, University of Chicago).  
     For protein production and purification, pMAL-t-AidC was used to transform E. coli 
BL21(DE3) cells.  The resulting E. coli BL21(DE3)(pMAL-t-AidC) cells were incubated at 37 
°C while shaking in Luria-Bertani (LB) medium supplemented with 100 µg/mL ampicillin. 
When the culture OD600 value reached 0.6-0.8 absorbance units, expression of the MBP-t-AidC 
fusion protein was induced by addition of 0.3 mM IPTG. The LB medium was supplemented 
with 0.5 mM ZnSO4, and expression was continued for an additional 16-18 h at 25 °C after 
induction.  Cells were harvested by centrifugation at 12400 × g, washed with Wash Buffer (20 
mM Tris-HCl buffer with 200 mM NaCl at pH 7.4), and stored at -80 °C after flash freezing in 
liquid nitrogen. The frozen cell pellet was thawed, sonicated in Wash Buffer, and centrifuged at 
40000 × g to pellet cell debris, which was discarded. The resulting supernatant was loaded onto 
an amylose affinity column (16 × 25 mm Dextrin Sepharose – MBL Trap HP, GE LifeSciences, 
preequilibrated with Wash Buffer).  The column was washed with Wash Buffer and the MBP-t-
AidC fusion protein was eluted from the column using Wash Buffer supplemented with maltose 
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(10 mM).  Fractions were evaluated using coomassie-stained SDS-PAGE, and those fractions 
containing MBP-t-AidC were combined and treated batch-wise with TEV protease, following 
previously published protocols.48 The resulting cleaved proteins were exchanged into Ion 
Exchange Buffer (20mM Tris-HCl, 5mM NaCl at pH 7.5) and loaded onto a column (XK 16/20 
GE LifeSciences) loaded with diethylaminoethanol (DEAE)-sepharose ion exchange resin to 
separate MBP, TEV protease and the untagged AidC.  The column was equilibrated with Ion 
Exchange Buffer (20 mM Tris-HCl, 5 mM NaCl at pH 7.5) and after loading, the protein eluted 
by a linear gradient between Ion Exchange Buffer and the same buffer supplemented by 1 M 
NaCl.  Fractions containing untagged AidC protein were pooled, concentrated using a 10,000 
molecular weight cut off (MWCO) Amicon-Ultra centrifugal filter device (Millipore, MA), and 
further purified by size exclusion chromatography using a HiLoad Superdex-200PG column, 16 
× 600 mm (GE Lifesciences, CA).  The column was equilibrated and the protein was purified 
using Size Exclusion Buffer (50 mM HEPES buffer, 300 mM NaCl, pH 7.5).  During the 
purification, fractions were assayed for the presence of MBP-t-AidC or AidC at each step by 
using 12% SDS-PAGE, followed by staining with EX-Run Gel Staining Solution (Fisher 
BioReagents) to detect bands at ~ 75 or ~ 32 kDa, respectively.  The final purified untagged 
AidC protein appeared homogenous when characterized on a Coomassie-stained 12% SDS-
PAGE gel.  Protein concentrations in solution were measured using bovine serum albumin 
(BSA) standards and the Bradford assay (BioRad).  This purification procedure typically results 
in a yield of 10 mg of purified untagged AidC / L culture media.    
Determining the zinc dependence, steady-state kinetic parameters, and zinc content of purified 
AidC  
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     Substrate hydrolysis rates were monitored using a previously described continuous 
spectrophotometric assay in which the pH indicator phenol red acts as part of the Assay Buffer (1 
mM Hepes at pH 7.5), and results in a change in colorimetric signal upon protonation by the net 
release of a proton upon lactone hydrolysis.48 The optimal Assay Buffer zinc concentration was 
determined by monitoring hydrolysis of saturating concentrations of C6-HSL (1 mM) as 
catalyzed by AidC (27 nM) to determine the maximum observed initial rates upon varying the 
zinc concentration (0 – 100 µM).  To determine the relationship between AidC concentration and 
kcat, the substrate t-BOC-HSL (5 mM) was used at saturating concentrations while the enzyme 
concentration was varied (0 – 250 nM).  The concentration of AidC was determined using a 
calculated20 extinction coefficient (ε280 =  29160 M-1cm-1).  The stoichiometry of bound zinc ions 
to protein in purified AidC was determined by dividing the total zinc concentration determined 
using the colorimetric chelator 4-(2-pyridylazo)resorcinol under denaturing conditions, as 
described previously,68 by the concentration of AidC.  
Crystallization 
     Purified AidC was concentrated to 20 mg/mL using a 10,000 molecular weight cut off 
(MWCO) Amicon-Ultra centrifugal filter device (Millipore, MA), and the concentrated protein 
was buffer exchanged into Crystallization Screening Buffer (50mM HEPES, pH 7.0). 
Crystallization screens  (Crystal Screen 1 & 2, Crystal Screen Cryo 1 & 2, PEG Ion 1 & 2 and 
Index1 & 2 from Hampton Research and Wizard 1 & 2 from Emerald BioSystems) were 
prepared using a Crystal Gryphon (ArtRobbins) crystallization robot using a ratio of 1:1 for Well 
Solution: AidC stock solution (20 mg/mL). Crystals appeared in the well solution containing 
MgCl2.6H2O (0.2 M), Bis-Tris (0.1 M), pH 6.5, 25 % (w/v) PEG 3350 after a week when 
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incubated at room temperature.  Crystallization was repeated and optimized using a 1:2 ratio 
of Well Solution:AidC (20 mg/mL) in sitting drops, and seeded on day 3 with AidC crystals 
obtained from previous trials.  Crystallization was done in 24 well Cryschem Plates (Hampton 
Research).  For co-crystallization of AidC and substrate, 4 µL of AidC (20 mg/mL) was mixed 
with 1 µL of Well Solution and 1 µL of 10 mM C6-HSL (dissolved in 50 % methanol). Crystals 
formed within a week after seeding, during which C6-HSL likely hydrolyzed to the ring-opened 
product N-hexanoyl-L-homoserine (C6-Hse).  AidC and AidC:C6-Hse crystals with the best 
morphology were transferred into a cryo-protecting solution (Well Solution supplemented with 
25 % (v/v) glycerol) and then into liquid nitrogen.  
Data collection and processing 
     Monochromatic data sets were collected at the 19-BM beamline at the Structural Biology 
Center (SBC), Advanced Photon Source (APS) at Argonne National Laboratory (ANL).  
Diffraction data was collected at a wavelength of 0.98 Å at 100 °K using a Quantum 210r 
Charge Coupled Device (CCD) detector from Area Detector Systems Corporation (ADSC).  All 
collected data sets were indexed and integrated using iMosflm69 and scaled using Scala in the 
CCP4 program suite.70 The best data sets were processed at resolutions of 1.09 Å and 1.67 Å for 
AidC and AidC:C6Hse, respectively.  Data collection statistics are summarized in Table 1.  
Structure determination, model building and refinement   
      The AidC structure was solved by molecular replacement using PHASER in the Phenix 
software suit.71 The initial search model was a poly-alanine model created based on a previously 
published structure of the organic phosphotriesterase OPHC2 (PDB Code: 4LE6; 
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Organophosphate hydrolase C2 from Pseudomonas pseudoalcaligenes),56 because this enzyme 
shares 26 % amino acid sequence identity with AidC.  The program Phenix.Autobuild was used 
to build the residue side chains based on the phases obtained from running PHASER; 
Phenix.Autobuild uses iterative cycles of model building and refinement until no more side 
chains can be built in automatically.71 The AidC:C6Hse structure was solved by molecular 
replacement using PHASER in the CCP4 software suit; the search model was the unliganded 
AidC structure.70 Both models were rebuilt and refined using the program Phenix24 and analyzed 
using the programs COOT72 and UCSF Chimera.73 Final refinement statistics are presented in 
Table 1.  Structural figures were made using UCSF Chimera.   
Determining oligomeric states of AidC and AiiA  
       To determine the molecular mass of AidC oligomers in solution, we used size-exclusion 
chromatography coupled with multi-angle light scattering (SEC-MALS). Our experimental setup 
included an AKTA FPLC (GE Healthcare Biosciences) with a silica-based size-exclusion 
chromatography column (WTC-030S5; Wyatt Technology) as a liquid chromatography unit. 
Downstream of the column is a refractive index detector (Optilab T-rEX; Wyatt Technology), 
followed by a multi-angle light scattering detector (Dawn Heleos II; Wyatt Technology) used for 
determining protein concentration and particle size, respectively.  As a control sample, we 
analyzed the related AHL lactonase AiiA, which is of similar monomeric size and has previously 
been demonstrated by analytical ultracentrifugation to be a monomer in solution.13 Each sample 
injection consisted of approximately 0.5 to 1 mg (injection volume 95 µL) of purified protein 
(either AiiA or AidC) in buffer containing 50 mM HEPES, 300 mM NaCl at pH 7.5. Flow rate 
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was set at 0.4 mL / min, and data were collected at 2 second intervals. Data processing and 
analysis were performed using the ASTRA software (Wyatt Technology).  
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CHAPTER THREE 
N-(2-OXOCYCLOBUTYL) DECANAMIDE AS A TRANSITION STATE MIMETIC FOR AN 
AHL LACTONASE AiiA FROM Bacillus Thuringiensis 
INTRODUCTION 
     Enzymes capable of hydrolyzing N-acyl-L-homoserine (AHL) lactones are of important 
significance because they disrupt the signal molecule used in cell-to-cell communication in 
bacteria1. Studying the mechanism of these enzymes provides insight into bacterial quorum 
sensing and is useful when designing more efficient quorum quenching enzymes. AiiA, a 
metalloenzyme enzyme from Bacillus sp. is the best characterized AHL-lactonase to date.  Based 
on structural and functional studies, a catalytic mechanism has been proposed for AiiA (Figure 
20).12,13,14 The crystal structures of AiiA (Figure 20:I)13 and AiiA bound to product (Figure 
20:V)13,14 represents two states in the catalytic cycle. Structural data supports three states of the 
enzyme represented as I, IV and V in the proposed mechanism in Figure 20.  
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Figure 20: Proposed mechanism for AiiA 
 
     To gain further insight into the mechanism of AiiA lactonase, we collaborated with the 
Becker group at Loyola University, Chicago to study N-(2-oxocyclobutyl) decanamide (2) as an 
analog to trap the proposed tetrahedral transition-state in the mechanism of AiiA. Inhibition 
assays were performed at varying concentrations of (2). Co-crystallization of AiiA-Co with (2) 
revealed the structure of a ring-opened byproduct ––4-decanamideobutanoic acid (3). 
Experiments were performed to determine if the ring-opened byproduct (3) was formed by 
enzyme mediated catalysis or as a result of exposure to X-ray radiation during data collection.  
 
RESULTS AND DISCUSSION 
     Kinetic assays were conducted to test the effects of (2) on the activity of AiiA-Co and 
crystallography experiments were conducted to gain structural insight into the mechanism of 
AiiA. 
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Inhibition Assay of AiiA-Co with N-(2-oxocyclobutyl) decanamide (2) 
     A previously published continuous assay with details described in methods was used to test 
the effects of (2) on the activity of AiiA by plotting activity versus concentration of N-(2-
oxocyclobutyl) decanamide (2).  
     Inhibition assays were carried out at substrate (C7-HSL) concentrations of 0.5, 1.0 and, 
2.5mM. The IC50 values at these 3 concentrations were 0.06 ±0.02, 0.10±0.03 and, 0.38±0.04, 
respectively. Figure 21 shows the plots of activity (Au/s) versus concentrations of the inhibitor 
(2).  
 
Figure 21: The plots show inhibition (C10 cyclobutanone) curves at substrate (c7homoserine lactone) 
concentrations of 0.5, 1.0, 2.5mM, respectively.  
   The plots show the IC50 value increases with increase in concentration of substrate. From this 
data we can conclude that N-(2-oxocyclobutyl) decanamide is a competitive inhibitor of AiiA.  
Crystal Structure of AiiA-N-(2-oxocyclobutyl) decanamide  (AiiA-C10CBO) 
     The structure of AiiA-C10CBO was solved by molecular replacement using a monomer of a 
known AiiA-Zn structure as a search model (PDB: 2A7M) after deleting all water and ligand 
molecules in the space group P212121. Multiple cycles of model building and refinement were 
conducted and the final model was refined to a resolution of 1.6 Å with Rfree/Rwork values of 
20.64/17.72. Final refinement statistics are shown in Table 4.  
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Figure 22: Active site of AiiA-C10CBO. A. The atoms representing the protein are shown in tan and the 
metal atoms (Cobalt) are shown in pink. Heteroatoms oxygen and nitrogen are represented in red and 
blue, respectively. C10CBO is shown in green. B. Represents a Fo-Fc map shown as a pink mesh at 2.5σ.  
     There are no changes in the overall structure of AiiA-C10CBO when compared to that of 
AiiA. The extra density at the active site after model building and refinement of the protein and 
solvent molecules was interpreted as 4-decanamideobutanoic acid (3) (Figure 22A). Figure 22B 
shows a Fo-Fc map at 2.5σ superimposed with a model of (3). The structure of the active site of 
AiiA bound to (3) shows cleavage of a C-C bond occurred when (2) was co-crystallized with 
AiiA. However, it is uncertain if this ring-opening reaction occurred during catalysis by the 
enzyme while soaking (2) with AiiA crystals, or due to X-ray radiation during data collection.  
In the crystal structure of AiiA-Zn bound to the product C6 homoserine (PDB:3DHB), a water 
molecule bridges the two Zn atoms at the active site. This structure is proposed to represent the 
active site of AiiA during product release and regeneration with the bridging water. In the crystal 
structure of AiiA-C10CBO we do not see a bridging water in the active site at AiiA. This 
position is possibly occupied by the oxygen atoms of (3) as seen on Figure 22. Therefore the 
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formation of byproduct (3) in the crystal structure of AiiA-C10CBO, possibly depicts one of 
the intermediates that is formed during the enzyme mechanism of AiiA (Figure 20). 
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Table 4.  Crystallographic Data for AiiA-C10CBO 
	  
	  
aRmerge = Σ|Iobs − Iavg|/ΣIavg. 
bThe values for the highest-resolution bin are in parentheses. 
cPrecision-indicating merging R  
dPearson correlation coefficient of two “half”data sets.  
eRwork = Σ|Fobs − Fcalc|/ΣFobs.  
fFive percent of the reflection data were selected at random as a test set, and only these data were used to calculate 
 AiiA-C10CBO 
Data Processing 
Space group P212121 
Cell dimension  
α, β, γ (deg) 90.0, 90.0, 90.0  
a, b, c (Å) 54.7, 55.6, 80.6 
Resolution (Å) 1.54 
Resolution at I/σ (I) = 2 1.66 
Rmerge a (%) 8.0(125.2)b 
I/σ (I) 17.7(1.05) 
Rpim c (%) 5.5(83.3) 
CC ½ d 0.998(0.361) 
Completeness (%) 98.2(88.0) 
Multiplicity   5.5(2.7) 
No. Reflections 210994 
No. Unique Reflections 38625 
Refinement 
  
Rwork e/Rfree f(%) 17.72/20.64 
No. of Atoms  
protein 2086 
ligand 270 
  
water                    18 
B factors  
protein 19.3 
ligand 20.7 
Rmsd g  
bond lengths (Å) 0.008 
  bond angles (deg) 1.045 
Ramachandran plot (%)  
most favored 96.0 
allowed 3.6 
outliers 0.4 
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Rfree. 
 gRoot-mean square deviation. hNot applicable. 
 
HPLC analysis to test formation of ring-opened analog via an enzyme mediated mechanism. 
(Collaboration with Cory Reidl at Becker Lab) 
     To determine the rate of formation of the ring opened product (3), a discontinuous HPLC 
assay was carried out using the methods described. HPLC analysis did not reveal any detectable 
ring-opened by-product (3). The results of this assay suggest the formation of the by-product 
could occur via a radical mechanism that occured due to x-ray radiation damage during data 
collection at the synchrotron radiation source.  
Chemically induced formation of radicals to test formation of ring-opened analog via a radical 
mechanism. (Experiments Conducted by Cory Reidl at Becker Lab). 
      The results of the chemically induced ring-opening experiments were inconclusive due to 
limitations in generating controlled doses of radicals. The results of these experiments were 
analyses by HPLC at different time intervals but, there was no detectable formation of (3).  
General discussion on possible mechanism for the formation of by-product (3) 
      The detailed mechanism for formation of the ring-opened by-product (3) cannot be 
elucidated based on our current results. However, the experimental data suggests the formation 
of (3) occurred via radiation damage that occurred during data collection. If, AiiA alone 
catalyzed this ring-opening reaction, the formation of (3) would be detectible in the HPLC assay. 
We can speculate that the mechanism was initiated by formation of a radical during x-ray data 
collection. The radicals formed could be stabilized by the two cobalt atoms in the active site of 
AiiA.  Tyr 194 in AiiA has been reported 2 as a H-bond donor to stabilize an intermediate during 
catalysis. Hence, it is reasonable to suggest Tyr194 could participate in this reaction by 
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stabilizing a radical involved in this mechanism. Our efforts to generate radicals using 
chemical reactions in solution were inconclusive. HPLC analysis showed the complete 
degradation of (2). This could imply that (2) must bind specifically to the active site of AiiA so 
the cyclobutanone ring is positioned in a conformation that allows only the C-C bond present 
between C2’and C3’ of the ring to be cleaved. Alternately, the natural substrates of AiiA are 5 
membered lactone rings. The binding of a 4 membered cyclobutanone ring to the active site of 
AiiA-Co, coupled with the x-ray radiation damage during data collection could have forced ring 
opening to form a conformation that has a closer resemblance to a 5 membered lactone ring.  
CONCLUSION 
     N-(2-oxocyclobutyl) decanamide is a competitive inhibitor of AiiA. AiiA along with X-ray 
radiation caused a ring opening reaction that produced a byproduct 4-decanamideobutanoic acid 
(3). The formation of byproduct (3) in the crystal structure of AiiA-C10CBO, possibly depicts 
one of the intermediates that is formed during the enzyme mechanism of AiiA.  
METHODS AND MATERIALS 
 Inhibition Assay  
      Rate of decrease of substrate hydrolysis were monitored using a previously described 
continuous spectrophotometric assay48 in which the pH indicator phenol red acts as part of the 
assay buffer [1 mM HEPES (pH 7.5)], which results in a change in the colorimetric signal upon 
protonation by the net release of a proton upon lactone hydrolysis. Stock solutions of the 
substrate (C7-HSL) and inhibitor (C10cyclobutanone) were prepared in methanol. Continuous 
spectrometric kinetic assays were used to determine initial hydrolyses rates by mixing substrate 
(0.5-2.5mM) and inhibitor (0.015-0.5mM) with assay buffer in a 1mL polystyrene cuvette.  Each 
reaction was initiated by the addition of purified enzyme and the reaction was monitored 
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continuously at 557nm. 
Crystallization  
      The purified AiiA-Co protein was concentrated to 20mg/mL using an Amicon-Ultra (30000 
MWCO), centrifugal filter device (Millipore, MA) and the protein was exchanged into 50mM 
HEPES buffer pH 7.0. The crystallization was carried out in hanging drops by using previously 
published conditions2. Crystals were obtained from the solution containing 160mM MgCl2.6H20, 
80mM Bis-Tris pH8.5, 24% w/v PEG 4000, by using a protein:well solution ration of 1:1. 
Crystals appeared within a week when incubated at 20°C along with slight precipitation. AiiA-
Co crystals with the best morphology were soaked overnight in a well solution containing 25mM 
C10cyclobutanone and 25% glycerol and cryo-cooled in liquid nitrogen.  
Data Collection and Processing 
     Monochromatic data sets were collected at the 19-BM beamline at SBC, Advanced Photon 
Source (APS) at Argonne National Laboratory (ANL).  Diffraction data was collected at a 
wavelength of 0.98Å, at 100K using an ADSC Quantum 210r CCD detector. All collected data 
sets were indexed and integrated using HKL3000. The best data set was processed at a resolution 
of 1.6Å.  
Structure Determination, Model Building and Refinement 
     The AiiA-C10cyclobutanone structure was solved by molecular replacement using PHASER 
in the Phenix software suit71. The initial search model was based on a previously published 
structure of AiiA-Zn (PDB Code: 2A7M). Models were rebuilt using COOT72 and refined using 
the program Phenix and analyzed using the programs COOT and UCSF Chimera73. The inhibitor 
was build and regularized using the software JLigand and fit into the difference density in 
COOT. Structural figures were made using UCSF Chimera.   
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CHAPTER FOUR 
SELECTIVE TARGETING BY A MECHANISM-BASED INACTIVATOR AGAINST 
PLP-DEPENDENT ENZYMES: MECHANISMS OF INACTIVATION AND ALTERNATIVE 
TURNOVER 
Summary 
      Potent mechanism-based inactivators can be rationally designed against PLP-dependent drug 
targets, such as ornithine aminotransferase (OAT) or γ-aminobutyric acid aminotransferase 
(GABA-AT). One of the remaining challenges is the lack of selectivity towards other PLP-
dependent off-target enzymes, due to similarities in mechanisms of all PLP-dependent 
aminotransferase reactions. Based on complex crystal structures, we investigate the inactivation 
mechanism of OAT, a Hepatocellular Carcinoma (HCC) target, by (1R,3S,4S)-3-amino-4-
fluorocyclopentane-1-carboxylic acid (FCP), a known inactivator of GABA-AT. A crystal 
structure of OAT and FCP showed the formation of a ternary adduct. This adduct is likely 
derived via an enamine mechanism of inactivation similar to that reported for GABA-AT. On the 
other hand, the crystal structures of an off-target PLP-dependent enzyme aspartate 
aminotransferase (Asp-AT) in complex with FCP, along with attempted inhibition assays, 
suggest that FCP is not an inactivator of Asp-AT, but rather an alternate substrate. Turnover of 
FCP by Asp-AT is also supported by high resolution mass spectrometry. In comparison to the 
inactivation mechanisms of FCP against OAT and GABA-AT, the obtained results provided 
evidence that desired selectivity of inactivation could be achieved, taking advantage of subtle 
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structural and mechanistic differences between a drug target and an off-target enzyme, despite 
their largely similar substrate binding sites and catalytic mechanisms.   
Introduction 
     Pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, is a coenzyme in a variety of 
enzymatic reactions. Aminotransferases are a class of PLP-dependent enzymes that catalyze 
myriad biochemical reactions involving amino acid metabolism, amino acid-derived metabolites, 
and the biosynthesis of amine-containing compounds.74,20 The importance of these enzymes is 
further highlighted because some of them have been identified as drug targets. For example, 
inhibition of γ-aminobutyric acid aminotransferase (GABA-AT) was proven effective in the 
treatment of many neurological disorders 24, and inhibition of ornithine aminotransferase (OAT) 
was shown to suppress the growth of hepatocellular carcinoma (HCC)25. Although reactions 
catalyzed by PLP-dependent enzymes appear diverse, they all share a similar catalytic 
mechanism that makes it challenging to design specific inactivators for each of these enzyme 
drug targets without effecting one another or other PLP-dependent, off-target enzymes like 
aspartate aminotransferase (Asp-AT). 
     Through the general mechanism of aminotransferases, Asp-AT catalyzes a reversible 
transamination converting L-aspartate and α-ketoglutarate to oxaloacetate and L-glutamate 
(Scheme 6c).28 During the catalysis, the cofactor is interconverted between its PLP and 
pyridoxamine (PMP) forms, facilitating the aminotransferase reaction.  The Asp-AT reaction is 
crucial in both amino acid degradation and biosynthesis.75 Therefore, when designing an 
inactivator for PLP-dependent drug targets, any molecule that also inhibits/inactivates Asp-AT or 
similar off-target enzymes may not be a promising molecule for further pharmacological 
development due to possible side effects.  OAT and GABA-AT are confirmed PLP-dependent 
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enzyme drug targets.23 Ornithine aminotransferase, (OAT; EC 2.6.1.13) catalyzes the transfer 
of the δ-amino group of L-ornithine to α-ketoglutarate, forming glutamate γ-semialdehyde and L-
glutamate (Scheme 6a). OAT is overexpressed in HCC cells, and its inhibition was shown to 
suppress their growth.27 GABA-AT (EC 2.6.1.19) catalyzes the transfer of the amino group of 
GABA to α-ketoglutarate, producing succinic semialdehyde and L-glutamate (Scheme 6b). 
GABA is a principle neurotransmitter in mammalian cells,76 and abnormally low levels of 
GABA in the brain have been associated with many neurological disorders including epilepsy, 
Parkinson’s disease, Huntington’s disease and Alzheimer’s disease.23 Inhibition of GABA-AT to 
raise the brain level of GABA has been proven beneficial in the treatment of these neurological 
disorders. Development of small molecules that selectively target a specific PLP-dependent 
enzyme is challenging. Much of the effort has focused on the design of mechanism-based 
inactivators, which are unreactive compounds that require the catalytic activity of the enzyme to 
convert them into reactive species that then inactivate the enzyme. Because these molecules are 
not initially reactive, indiscriminate reactions with many off-target proteins, leading to undesired 
side effects, should be greatly reduced. 
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Scheme 6. General mechanism of A) Aspartate Aminotransferase, B) Ornithine Aminotransferase and 
C) GABAAminotransferase  
 
     In this study, we investigated the mechanism by which (1R,3S,4S)-3-amino-4-
fluorocyclopentane-1-carboxylic acid (FCP) a known inactivator of GABA-AT and OAT26, 
inactivates OAT, and the effects of FCP on a PLP-dependent off-target Asp-AT. Our study 
serves as a proof-of-principle that new OAT inactivators could be developed from GABA 
analogues, without targeting other off-target PLP-dependent enzymes. Previously Storici et al. 
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studied the inactivation of GABA-AT by FCP.77 It inactivated GABA-AT through an enamine 
mechanism (Figure 23A), with the crystal structure of the inactivated enzyme showing the 
adduct derived from this mechanism (5). In this study, we obtained the crystal structure of 
inactivated OAT by FCP and provide implications about the mechanism. We also report the 
crystal structures of the off-target Asp-AT in complex with FCP in the presence as well as in the 
absence of α-ketoglutarate. The crystal structures of Asp-AT in complex with FCP, along with 
inhibition assays and high resolution mass spectrometry, support the turnover of FCP by Asp-AT 
and the proposed mechanism.  
 
Figure 23. Mechanism of inactivation of GABA-AT by FCP A) Scheme representing the mechanism of 
inactivation of GABA-AT by FCP. B) Crystal structure of the inactivated GABA-AT showing the adduct 
derived from an enamine mechanism (5)11 
Results and Discussion 
      One of the biggest challenges that must be overcome when designing a mechanism based 
inactivator as a drug is to avoid negative effects caused by possible inactivation of similar off-
target enzymes. FCP, a known inactivator of GABA-AT and OAT, is studied for its mechanism 
 73 
of inactivation of OAT (the drug target) and its effects on Asp-AT (off-target). To compare the 
effects of FCP on all three enzymes, we cloned, expressed, and purified human OAT and 
purified Asp-AT for structural and biochemical studies. The cloning results were confirmed by 
DNA sequencing. Heterologous expression of OAT and Asp-AT in E. coli BL21(DE3) cells led 
to good yields of purified proteins (~ 10 mg/L culture and ~30mg/L culture, respectively). The 
proteins were characterized and used for biochemical and structural studies as described in 
Methods and Materials 
Inactivation of OAT by FCP 
      FCP was previously shown to inactivate GABA-AT with a KI of 49 mM and kinact of 0.18 
min-1 (kinact/KI = 0.0013 mM-1min-1) and inactivate OAT with a KI of 3.5 mM and kinact of 0.11 
min-1 (kinact/KI = 0.03 mM-1min-1)26.  Due to irreversible inactivation, FCP is a potent inactivator 
for both GABA-AT and OAT.  However, no inactivation studies have been conducted on Asp-
AT.  Based on a reported complex structure77, FCP inactivates GABA-AT through an enamine 
mechanism (Figure 23A).  
      Here, studies were conducted to gain structural insight into the mechanism of inactivation of 
OAT by FCP. OAT inactivated by FCP (OAT-FCP) was crystallized and the structure of OAT-
FCP was solved by molecular replacement using a monomer of a known OAT structure as a 
search model (PDB: 1OAT) after deleting all water and ligand molecules. In spacegroup P321, 
three monomers were found in one asymmetric unit. Multiple cycles of model building and 
refinement were conducted, and the final model was refined to a resolution of 1.8Å with 
Rfree/Rwork values of 21.3/18.4. Final refinement statistics are shown in Table 5. 
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Table 5. Crystallographic Data for OAT_FCP, Asp-AT_FCP and Asp-AT_FCP-KG 
 OAT_FCP ASP-AT_FCP ASP-AT_FCP_KG 
Data Processing 
Space group P 32 2 1 P1 C 2 2 21 
Cell dimension    
α, β, γ (deg) 115.3, 115.3, 187.9 118.8,90.1,89.6 84.4, 155.5,77.4 
a, b, c (Å) 90, 90, 120 78.9,84.9,88.0 90.0, 90.0, 90.0 
Resolution (Å) 1.78 1.80 1.72 
Resolution at I/σ (I) = 2 1.84 1.80 1.75 
Rmerge a (%) 9.3 (0.0)b 6.1(40.0) 4.0(98.0) 
Rpim c (%) 3.9 (79.3) - 2.7(53.0) 
I/σ (I) 26.2 (1.47) 20.0(2.8) 25.3(1.9) 
CC ½ d 0.998(0.568) - 0.998(0.701) 
Completeness (%) 99.8(99.0) 98.2(83.4) 99.7(99.5) 
Multiplicity 9.4 (7.5) 3.8(3.3) 4.3(4.0) 
No. Reflections 1315591 676385 240049 
No. Unique Reflections 139552 178845 55946 
Refinement 
    
Rwork e/Rfree f(%) 17.78/20.99 16.39/18.77 16.7/19.04 
No. of Atoms    
protein 9626 13737 3105 
ligand  32 63 25 
    
water 1309 1434 366 
B factors    
protein 26.4 31.1 25.2 
ligand 16.7-32.9 17.7-32.7 35.9 
RMSD g    
bond lengths (Å) 0.007 0.007 0.007 
bond angles (deg) 1.115 1.124 1.138 
Ramachandran plot (%)    
most favored 96.41 97.19 95.77 
allowed 3.27 2.59 4.23 
outliers 0.33 0.22 0.00 
aRmerge = Σ|Iobs − Iavg|/ΣIavg 
bThe values for the highest-resolution bin are in parentheses 
cPrecision-indicating merging R  
dPearson correlation coefficient of two “half”data sets   
eRwork = Σ|Fobs − Fcalc|/ΣFobs 
fFive percent of the reflection data were selected at random as a test set, and only these data were used to calculate Rfree 
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gRoot-mean square deviation  
hNot applicable 
       No major conformational changes were observed when the known structure of OAT 
(PDB:1OAT) was compared to OAT_FCP. The active site of OAT_FCP (Figure 24A) displays a 
ternary adduct formed between Lys292, PLP and, FCP. The atom C-4 of PLP, at which three 
parts of the ternary adduct join covalently, are refined with an R-configuration and tetrahedral 
geometry (Figure 24A). This ternary adduct is similar to the adduct observed in the active site of 
the crystal structure of inactivated GABA-AT by FCP 77 (Figure 23B). 
 
Figure 24. Structure of adduct formed between OAT, PLP and FCP. Protein atoms are shown as sticks, 
with oxygen colored red, nitrogen blue and phosphorous in orange. A) Active site of OAT showing the 
ternary adduct formed between K292, FCP and PLP are shown in yellow. The dashed lines represent the 
electrostatic interactions between active site residues of OAT (green) and the adduct. B) Simulated 
annealing omit map (Fo-Fc ) of the adduct. The omit map is shown as a grey mesh at 3σ. The omit map 
was generated after omitting FCP, PLP and K292 from the coordinates.  
       In OAT_FCP, Arg180 forms a salt bridge with the carboxyl group of FCP; this non-covalent 
interaction has been reported to be important for substrate binding at the active site.23 Figure 24B 
shows a simulated annealing omit map (Fo-Fc) superimposed with the ternary adduct. The 
formation of this adduct implies that the inactivation of OAT by FCP proceeded via an enamine 
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mechanism, similar to that of the inactivation of GABA-AT by FCP. This mechanism is 
initiated by a formation of the Schiff base between FCP and PLP (1), followed by a γ-proton 
removal and tautomerization that leads to the release of the fluoride ion and enamine 7 (Scheme 
7). Subsequent nucleophilic addition of 7 to the lysine-bound PLP on OAT gives rise to the 
ternary adduct 8, which is similar to 5 in the inactivation mechanism of GABA-AT by FCP.  
Scheme 7. Proposed mechanism of inactivation of OAT by FCP.  
 
Reaction of FCP and its Effects on Asp-AT 
       E. coli Asp-AT is similar to Homo sapiens (human) Asp-AT with over 40% sequence 
identity and is a model enzyme among Asp-AT’s, which are known to catalyze reactions with the 
same mechanism 2,28. Overexpressed and purified E. coli Asp-AT has been used as the off-target 
model enzyme to design inactivators against PLP-dependent enzymes78,79. The results showed 
FCP did not inactivate or inhibit the activity of Asp-AT at up to 10 mM concentration (Figure 
25).  
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Figure 25. Enzyme activity of Asp-AT at various concentrations of FCP 
 
      Cocrystallization of Asp-AT and FCP in the absence of α-ketoglutarate (Asp-AT_FCP) 
yielded crystals that diffracted to 1.8Å. The data set was processed in space group P1 and the 
crystal structure was solved by molecular replacement using a known structure of Asp-AT (PDB: 
2AAT) as a search model. The resulting structure has 4 monomers per asymmetric unit, and the 
model was refined with Rfree/Rwork values of 18.7/16.4. Final refinement statistics are shown in 
Table 5. 
        The active site of Asp-AT_FCP (Figure 26A) contains electron density that is not consistent 
with the formation of a ternary adduct like observed in the crystal structures of FCP inactivated 
GABA-AT or OAT. Instead, this electron density is fit well by PMP (Figure 26). The 
discontinuity in the electron density between Lys246 and the putative pyridoxamine moiety 
provides evidence for the turnover of PLP to PMP. In addition, the electron density around C7 of 
the putative PMP fits well with an sp3 hybridized carbon, providing further evidence that the 
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moiety is in the pyridoxamine rather than the pyridoxal form. Figure 25B shows a simulated 
annealing omit map (Fo-Fc) superimposed with the atomic model of PMP. The interactions 
between active site residues and PMP (Figure 25A) in this crystal structure are the same as those 
in a previously reported structure of the Asp-AT_PMP holoenzyme80,81. Observation of PMP 
bound to Asp-AT in the presence of FCP suggests that Asp-AT catalyzes the conversion of the 
amine group on FCP to a keto group through the same mechanism it converts aspartate to 
oxaloacetate and this reaction stops at the generation of PMP after the first half of the “Ping-
pong” catalytic cycle. 
 
Figure 26. Structure of Asp-AT and PMP. Protein atoms are shown as pink sticks, with oxygen colored 
red, nitrogen blue and, phosphorous in orange. A) Active site of Asp-AT and PMP The dashed green lines 
represent the electrostatic interactions between PMP and residues of Asp-AT. B) Simulated annealing 
omit map (Fo-Fc ) of the adduct. The omit map is shown as a grey mesh .The omit map was generated 
after omitting PMP from the coordinates.  
       Based on our interpretation of the turnover of FCP by Asp-AT and conversion of PLP to 
PMP, it is expected that cocrystallization of Asp-AT in the presence of FCP and its second 
substrate––α-ketoglutarate, should reveal a structure representing regeneration of the enzyme 
back to the PLP form, as proposed in the second half of the Asp-AT catalytic cycle. 
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Cocrystallization of Asp-AT and FCP in the presence of α-ketoglutarate yielded crystals that 
diffracted to 1.7Å. Interestingly, the obtained complex structure (Asp-AT_FCP_α-ketoglutarate) 
revealed difference density at the active site that fits well with the model of a ketimine 
intermediate. This ketimine intermediate has long been proposed as a key intermediate in the 
Asp-AT catalytic mechanism before generating the final product glutamate and regeneration of 
the cofactor–PLP (Figure 27A). Ketimine intermediates have been previously trapped in the 
crystal structures of DesV from Streptococcus pneumonia (PLP-dependent transaminase)82 and, 
ColD from E.Coli (dehydratase),83,84 but to our knowledge not previously reported in Aspartate 
aminotransferase.  
 
Figure 27. Structure of Asp-AT with a ketimine intermediate. Protein atoms are shown as pink sticks, 
with oxygen colored red, nitrogen blue and, phosphorous in orange. A) Active site of Asp-AT and a 
ketimine intermediate formed between PMP and α-ketoglutarate are shown in yellow.The dashed green 
lines represent the electrostatic interactions between ketimine and residues of Asp-AT. B) Simulated 
annealing omit map (Fo-Fc ) of the adduct. The omit map is shown as a grey mesh .The omit map was 
generated after omitting the ketimine from the coordinates.  
      Figure 27B shows a simulated annealing omit map (Fo-Fc) superimposed with the atomic 
model of this ketimine intermediate. The carbon-nitrogen double bond formed between N-2 on 
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the pyridoxamine moiety and C-2 on α-ketoglutarate provided evidence for this ketimine 
intermediate. There was no electron density between Lys246 and the pyridoxal moiety, 
consistent with the measured distance of ~3.2Å. The carboxyl group on the α-ketoglutarate 
makes a salt bridge with Arg374. The phosphate group on the pyridoxal moiety interacts with 
Arg254 and Thr104 through hydrogen bonds. These electrostatic interactions are consistent with 
previous understanding to hold the substrate and cofactor in the active site during the catalytic 
transformation.28 Based on both complex crystal structures of Asp-AT, we propose that in the 
absence of α-ketoglutarate, Asp-AT turns over FCP to a keto product, and PLP is converted to 
PMP. In the presence of α-ketoglutarate, after the first half of the catalytic cycle occurs, PMP 
reacts with α-ketoglutarate to form a ketimine intermediate that is then hydrolyzed to L-
glutamate and PLP. Trapping this ketimine intermediate in the crystal structure is possibly an 
artifact during cocrystallization. Nonetheless, this ketimine intermediate provides evidence for 
the occurrence of the second half of the catalytic cycle and further suggests that FCP is an 
alternate substrate for Asp-AT.  
Proposed Mechanism of Alternative Turnover of FCP by Asp-AT 
      To test for turnover of FCP by Asp-AT and probe its turnover mechanism, we incubated 
Asp-AT with FCP in the absence of α-ketoglutarate, allowing the putative first half-reaction of 
FCP turnover to occur in a single turnover fashion. After desalting and deproteinating, FCP 
turnover samples were analyzed by high mass accuracy HPLC-ESI-MS/MS, using a Q-Exactive 
mass spectrometer in negative ion mode to detect reaction products. The abundance of ions with 
molecular formulae corresponding to several putative FCP-turnover products was observed to 
change significantly when FCP and Asp-AT were incubated together (Table 6, Figure 28).  
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Figure 28. Relative levels of proposed FCP turnover products and intermediates.  Relative abundance of 
each compound was determined by LC-MS.  Each compound was increased by incubation of FCP with 
Asp-AT, except for PLP.  Blank = acetonitrile.  Buffer = reaction buffer.  FCP = FCP at 15.8 mM.  Enz = 
Asp-AT at 39.5 µM.  Rxn. = Asp-AT (39.5 µM ) + FCP (15.8 mM).  
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Table 6. Proposed FCP turnover products and intermediates detected by mass spectrometry 
Compound Change 
Obs. 
m/z 
Theor. 
m/z 
Δ 
ppm 
Isotopic 
envelope 
supported? 
MS2 
Supported? 
Synthetic 
standard 
supported? 
9/10 Increase 375.077 375.076 4 N.D.a N.D. a N.A.b 
3 Increase 355.072 355.070 5 N.D. a N.D. a N.A.b 
PLP Decrease 246.017 246.017 1 Yes Yes Yes 
PMP Increase 247.049 247.049 0 Yes N.D. a Yes 
12 Increase 127.039 127.040 -7 Yes Yes N.A.b 
11 Increase 145.030 145.031 -4 N.D. a N.D. a N.A.b 
7 Increase 126.055 126.056 -7 Yes Yes N.A.b 
a compound was below limit of detection for MS2 or isotopic envelope 
b synthetic standard not available 
     Ions were putatively identified based on intact mass and when possible, isotopic envelopes, 
MS2 fragment assignment, and comparison to synthetic standards. Figure 30-33 present MS2 
and/or isotopic envelope evidence for identification of 3-oxocyclopentane-1-carboxylate (12), 
PLP, PMP, and 7. In some cases, analysis of isotopic envelopes and MS2 was not possible due to 
low overall abundance (Table 6).  The relative level of each of these metabolites is shown in 
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Figure 28.  Notably, each metabolite increased when FCP and enzyme were mixed, relative to 
negative controls, with the exception of PLP, which decreased.  This is consistent with the model 
proposed in Figure 29, where FCP turnover is partitioned between two separate pathways. The 
resulting Schiff base from the reaction of FCP and the lysine-bound PLP on Asp-AT is subjected 
to γ-proton removal, followed by tautomerization that leads to the formation of intermediates 9 
and 10 (path a) and the release of the fluoride ion (path b). In path a, hydrolysis of intermediate 
10 gives 3-fluoro-4-oxocyclopentane-1-carboxylate 11 and releases PMP. In path b, hydrolysis 
of 3, the intermediate formed after the release of the fluoride ion, gives enamine 7 and releases 
PLP; hydrolysis of 7 generates 3-oxocyclopentane-1-carboxylate 12. Pathways a and b occur 
concurrently. Intermediates 9 and 10, 3-fluoro-4-oxocyclopentane-1-carboxylate (11), 3-
oxocyclopentane-1-carboxylate (12), 7, and PMP increased in the incubated solution of FCP and 
Asp-AT. Only a portion of the PLP pool was reformed, following path b; hence, the level of PLP 
decreased in the incubated solution.  
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Figure 29: Proposed Turnover Mechanism of FCP by Asp-AT Based on Mass Spectrometry Analysis 
of Single Turnover of FCP. Species detected to be increased are boxed in green. Species detected to be 
decreased are circled in red. Isobaric ions are boxed with dashed lines. Both pathways a and b are 
proposed to occur concurrently.  Only a portion of the PLP pool was reformed, following path b; hence, 
the level of PLP decreased in the incubated solution 
 
 
Figure 30. MS2 fragment assignments for 3-oxocyclopentane-1-carboxylate produced by incubation of 
FCP with Asp-AT 
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Figure 31. Comparison of MS2 fragmentation of synthetic PLP standard and observed PLP product of 
FCP turnover by Asp-AT. 
 
 
Figure 32. MS1 isotopic envelope of PMP synthetic standard compared to the observed species from 
incubation of FCP with Asp-AT and the computer simulated isotopic envelope of C6H12N2O5P-. 
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Figure 33. MS2 fragment assignments for 7, produced by incubation of FCP with Asp-AT. 
Comparison of Complex Structures of OAT_FCP, GABA_FCP, and Asp-AT_FCP 
      OAT, GABA-AT and, Asp-AT (Figure 34) belong to Type-1 fold class of 
aminotransferases.85 Within this Type I fold class, Asp-AT belongs to subclass I (AT-I), while 
OAT and GABA-AT belong to subclass II (AT-II).33,85 Though these two subclasses are 
structurally homologous, detailed analysis reported in literature show that the N-terminal domain 
is not completely conserved and could be a cause for the subtle differences in their 
mechanisms.33,86,87 This could explain why FCP inactivates OAT and GABA-AT, but is an 
alternate substrate for Asp-AT. 
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Figure 34. Overlap of the secondary structures of OAT from PDB:1OAT (pink), GABA-AT from 
PDB:1OHV(cyan), and Asp-AT from PDB:2AAT (green) 
The active sites of GABA-AT and OAT are strikingly similar, and an alignment of these two 
structures showed no major differences in the positions of the conserved key catalytic residues 
(Figure 35A), including the catalytic Lys and an Arg that is involved in substrate binding. Lee et 
al.23 previously proposed that inactivators of GABA-AT could also bind to OAT since the 
distances between the catalytic Lys residue and the Arg residues are similar (Figure 35A). 
Therefore, it is reasonable that FCP inactivates both GABA-AT and OAT via a similar enamine 
mechanism. Despite the presence of the catalytic lysine and PLP, the active site residues in Asp-
AT do not align well with those of OAT and GABA-AT (Figure 35B), displaying subtle 
differences (Tyr 65 from subunit b and position of R254 for substrate recognition)28 that could 
contribute to the difference in mechanisms with FCP.  
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Figure 35. A) Overlap of the active sites of OAT(green) and GABA-AT(cyan) B) Overlap of the active 
sites of OAT(pink), GABA-AT(blue) and Asp-AT (green) 
       In the mechanisms of inactivation of OAT and GABA-AT by FCP (Figure 23A; Scheme 7), 
intermediate 7 is held in position in the active site closed to the Lys-bound PLP via a salt bridge 
between a conserved Arg and the carboxyl group on FCP, allowing 7 to irreversibly form a 
covalent adduct with the enzyme and PLP, which leads to the inactivation of the enzyme. In the 
mechanism of FCP with Asp-AT, this ternary adduct is not formed; instead, FCP is turned over 
to a keto product, which could be the result of the hydrolysis of 3 that happens before the ternary 
adduct is formed (Figure 29b). Examination of the active site pockets reveals that in OAT and 
GABA-AT, the pyridine ring of the cofactor is buried in the enzymes’ active sites and is barely 
exposed to the solvent (Figure 36 A,B), which likely helps to retain intermediates 6 and 4 in the 
active site cavities long enough for the formation of the final ternary adducts to occur. In Asp-
AT (Figure 36C), the pyridine ring of the co-factor is more exposed and closer to the surface of 
the protein, which may account for the availability of a water molecule for the hydrolysis of 3 to 
happen fast. 
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 Figure 36. Cofactor binding pockets. A) A surface coated OAT is shown in green and brown. PLP is 
represented as yellow sticks, with oxygen in red, nitrogen in blue and phosphorous in orange. The PLP 
pocket is buried in the protein. B) A surface coated GABA-AT is shown in green and purple. PLP is 
represented as yellow sticks, with oxygen in red, nitrogen in blue and phosphorous in orange. The PLP 
pocket is buried in the protein. C) A surface coated Asp-AT is shown in pink. PMP is represented as 
yellow sticks, with oxygen in red, nitrogen in blue and phosphorous in orange.  
      One difference between the active sites of Asp-AT and OAT is that Asp-AT positions a 
Tyrosine 214 instead of a threonine close to the PLP (Figure 37). When the two complex 
structures Asp-AT-PMP and OAT-PLP-FCP are superimposed, Tyrosine would place a water via 
a hydrogen bound close to the expected binding position of FCP, presenting an estimated 
distance of 3.3 Å to the point of nucleophilic attack.  Thus, this water could be the nucleophile 
that carries out the hydrolysis to complete the alternative turnover instead of inactivation in Asp-
AT. 
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Figure 37.  Two complex structures OAT-PLP-FCP and Asp-AT-PMP are superimposed.  The carbon 
atoms in OAT-PLP-FCP are shown in brown.  The carbon atoms in Asp-AT-PMP is shown in cyan.  The 
estimated distance of the water to carry out nucleophilic attack is shown in green.  
Selectivity of Mechanism-based Inactivators for PLP-dependent Enzymes 
      Though the active sites and catalytic mechanisms of GABA-AT and OAT are very similar, 
their substrates, GABA and ornithine, respectively, display certain structural differences. 
Ornithine is one carbon longer than GABA, and it has an additional amine group at the α-carbon. 
Previous studies on mechanism-based inactivators of these two enzymes showed that (S)-4-
amino-5-fluoropentanoic acid (AFPA)23 is specific for GABA-AT, and (2S,5S)-5-
fluoromethylornithine (5FMOrn)88 is specific for OAT. 5FMOrn is one carbon longer than 
AFPA, and it has an additional amine group at the α-carbon. An overlap of the active sites of 
GABA-AT and OAT (Figure 35), though very similar, show differences in a certain amino acids 
that could account for their selectivity for one substrate.  It has been suggested that residues 
Tyr55 and Tyr85 make the active site of OAT more flexible to accommodate substrates that are 
larger in size and have an amine group at the α-carbon, when compared to the hydrophobic 
environment in active site of GABA-AT that is created by residues Ile72 and Phe351.23 These 
subtle differences can be exploited when designing mechanism-based inactivators that are 
specific for either OAT or GABA-AT. 
Conclusion 
      FCP inactivates a drug target OAT via an enamine mechanism similar to that of another drug 
target GABA-AT, but is an alternative substrate for an apparent PLP-dependent off-target Asp-
AT. The proposed mechanisms of inactivation and alternative turnover in all three enzymes are 
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complex, and all contain multiple reaction pathways. Although FCP is still too toxic to 
become a drug89,77 itself, it displays a desirable selectivity in the context of drug development as 
a mechanism-based inactivator.  The reason for this desirable selectivity is due to the subtle 
differences in the shapes of the active site cavities for retaining an intermediate, as well as the 
availability of a water molecule for a proposed hydrolysis in a complex mechanism with multiple 
reaction pathways. In general, the reactive intermediates generated during the complex reactions 
of these mechanism-based inactivators in active sites could be capable of displaying desirable 
specificity of inactivation discerning drug targets and off-targets, even with similar structures 
and reaction mechanisms. 
Materials and Methods 
     Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO), 
and all enzymes used for cloning were purchased from New England Bio Labs (Beverly, MA). 
 Cloning, Expression, and Purification of Human OAT. 
      A shuttle vector (pCMV-SPORT6) carrying the OAT cDNA gene from Homo sapiens was 
purchased from plasmID (Harvard Medical School). The coding sequence for OAT was cloned 
in a pMAL-C5X vector for expression in Escherichia coli.  A sequence encoding the cleavage 
site for tobacco etch virus (TEV) protease (ENLYFQG) was inserted at the 5’ end of the OAT 
coding region using forward primer 5’gcgctcggggaaaacctgtattttcagggcgcctctgctacatctgttgcaac3’ 
and reverse primer 5’gcggaattctcagaaagacaagatggtc3’; restriction sites Ava1 and EcoR1were 
added to the 5’ and 3’ ends, respectively. A commercial protein expression vector, pMAL-C5X 
(New England Biolabs, Beverly, MA), was digested using restriction enzymes EcoR1 and Ava1, 
and the resulting PCR insert containing OAT coding region was ligated into the expression 
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vector using T4 DNA Ligase (New England Biolabs, Beverly, MA) to yield a protein 
expression plasmid encoding an N-terminal maltose binding protein (MBP) linked through a 
TEV cleavage sequence to the full length OAT enzyme.  The resulting vector (pMAL-t-OAT) 
was used to transform E.coli DH5α cells for plasmid storage and amplification.  The entire 
coding region in pMAL-t-OAT was verified by DNA sequencing. (CRC DNA Sequencing, 
University of Chicago).  
       For protein production and purification, pMAL-t-OAT was used to transform E. coli 
BL21(DE3) cells.  The resulting E. coli BL21(DE3) (pMAL-t-OAT) cells were incubated at 37 
°C while shaking in Luria-Bertani (LB) medium supplemented with 100 µg/mL ampicillin. 
When the culture OD600 value reached 0.6-0.8 absorbance units, expression of the MBP-t-OAT 
fusion protein was induced by addition of 0.3 mM IPTG, and the expression was continued for 
an additional 16-18 h at 25 °C after induction.  Cells were harvested by centrifugation at 12400 × 
g, washed with Wash Buffer (20 mM Tris-HCl buffer with 200 mM NaCl, 100µM PLP at pH 
7.4), and stored at -80 °C after flash freezing in liquid nitrogen. The frozen cell pellet was 
thawed, sonicated in Wash Buffer, and centrifuged at 40000 × g to pellet cell debris, which was 
discarded. The resulting supernatant was loaded onto an amylose affinity column (16 × 25 mm 
Dextrin Sepharose – MBL Trap HP, GE LifeSciences, pre-equilibrated with Wash Buffer).  The 
column was washed with Wash Buffer, and the MBP-t-OAT fusion protein was eluted from the 
column using Wash Buffer supplemented with maltose (10 mM).  Fractions were evaluated using 
coomassie-stained SDS-PAGE, and those fractions containing MBP-t-OAT were combined and 
treated batch-wise with TEV protease using previously published protocols90. Fractions 
containing untagged OAT protein were combined, concentrated using a 30,000 molecular weight 
cut off (MWCO) Amicon-Ultra centrifugal filter device (Millipore, MA), and further purified by 
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size exclusion chromatography using a HiLoad Superdex-200PG column, 16 × 600 mm (GE 
Lifesciences, CA). The column was equilibrated and the protein was purified using Size 
Exclusion Buffer (50 mM HEPES buffer, 300 mM NaCl, pH 7.5).  During the purification, 
fractions were assayed for the presence of MBP-t-OAT or OAT at each step by using 12% SDS-
PAGE, followed by staining with EZ-Run Gel Staining Solution (Fisher BioReagents) to detect 
bands at ~ 92 or ~ 49 kDa, respectively. The final purified untagged OAT protein appeared 
homogenous when characterized on a Coomassie-stained 12% SDS-PAGE gel. Protein 
concentrations in solution were measured using bovine serum albumin (BSA) standards and the 
Bradford assay (BioRad). This purification procedure typically results in a yield of 30 mg of 
purified untagged OAT/ L culture media.   
Purification of E. coli Aspartate aminotransferase 
        The pJO2 plasmid (provided by Dr. J. F. Kirsch) containing the wild-type aspC gene was 
transformed into the DH5α E. coli strain. The wild-type Asp-AT was overexpressed and purified 
by following a published protocol91. Accordingly, 0.1% of PLP was added to the expression 
culture. After the harvested cells were broken via sonication and the cell extract was centrifuged 
at 12400 × g, the supernatant was removed and mixed with PEG8000 that was slowly added to a 
final concentration of 20% of the total volume of the supernatant. The resulting suspension was 
again centrifuged at 12400 × g. The supernatant was diluted in a DEAE running buffer and run 
through a DEAE column and a hydroxyapatite column on a FPLC consecutively. For 
crystallization, an additional purification step was added using a HiLoad Superdex-200PG 
column, 16 × 600 mm (GE Lifesciences, CA). The final yield of the purified Asp-AT was 80-
100 mg/L of culture. For crystallization, the purified protein was exchanged into a 25mM 
potassium phosphate buffer at pH 6.0 and pH 8.0 with a final concentration of 10 mg/mL. A 
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solution of 1 mM PLP was supplemented to the protein solution to stabilize the enzyme. All 
purification procedures were carried out at or near 4°C. During the purification, fractions were 
assayed for the presence of Asp-AT at each step by using 12% SDS-PAGE, followed by staining 
with EZ-Run Gel Staining Solution (Fisher BioReagents) to detect bands at ~ 47kDa.  
Attempted Inhibition Assays of FCP against Asp-AT 
       Microtiter plate wells were loaded with 90 µL of an assay mixture containing potassium 
phosphate (100 mM, pH 7.4), α-ketoglutarate (5.55 mM), NADH (1.11 mM), L-aspartate (5.55 
mM), malate dehydrogenase (5.5 units), and various concentrations of FCP. After the mixture 
was incubated at room temperature for a few min, 10 µL of Asp-AT (2.0 units/mL in 100 mM 
potassium phosphate at pH 7.4) was added. The plate was shaken at room temperature for 1 min, 
and the absorbance was measured at 340 nm every 10 s for 60 min. All assays were performed in 
duplicate. 
Crystallization of OAT and FCP 
     OAT pre-inactivated by FCP was concentrated to 10 mg/mL using a 30,000 MWCO Amicon-
Ultra centrifugal filter device (Millipore, MA), and the concentrated protein was exchanged into 
a crystallization buffer (50mM Tricine HCl, pH 7.8 and 10µM PLP). Crystals were grown using 
previously published conditions.32 Crystallization was done in 24-well Cryschem Plates 
(Hampton Research). Crystals with the best morphology appeared in the well solution containing 
NaCl (175mM) and 8-10% (v/v) PEG 6000 after incubation at room temperature for a week. 
OAT crystals with the best morphology were transferred into a cryo-protecting solution (Well 
Solution supplemented with 25 % (v/v) glycerol) before being flash cooled in liquid nitrogen.  
Cocrystallization of Asp-AT and FCP in the Presence and Absence of α-Ketoglutarate   
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      The cocrystallization of Asp-AT and FCP in the absence of α-ketoglutarate was conducted 
using the hanging-drop method. The well solutions contained 25 mM potassium phosphate and 
43% saturated ammonium sulfate. Hanging drops were set up by mixing 4 µL of protein solution 
(10 mg/mL), 2 µL of FCP (50 mM, stock solution), and 4 µL of well solution. The pH values of 
the solutions were adjusted to pH 6.5. The crystals appeared overnight. The crystals were then 
transferred to a cryo-protectant solution that consisted of 48% saturated ammonium sulfate, 25 
mM potassium phosphate, 20% glycerol, and 1 mM PLP and was adjusted to the pH value at 
which the crystals were formed. The crystals were frozen in liquid nitrogen after dipping into the 
cryo-protectant solution. For the cocrystallization of Asp-AT and FCP in the presence of α-
ketoglutarate, the protein buffer was substituted with a solution of α-ketoglutarate (10mM); other 
crystallization conditions remained the same.  
Data Collection and Processing 
       Monochromatic data sets were collected at the LS-CAT, Advanced Photon Source (APS) at 
Argonne National Laboratory (ANL).  Diffraction data were collected at a wavelength of 0.98 Å 
at 100 K using a Mar300 Charge Coupled Device (CCD) detector. All collected data sets were 
indexed and integrated using HKL2000 suite92. Data collection statistics are summarized in 
Table 5.  
 Model Building and Refinement  
      The OAT structure and Asp-AT structures were solved by molecular replacement using 
PHASER in the Phenix software suit71. The initial search model was based on a previously 
published structure of OAT (PDB Code: 1OAT), and Asp-AT (PDB Code: 2AAT). Models were 
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rebuilt using COOT72, refined using Phenix71, and analyzed using COOT72 and UCSF 
Chimera73.  Final refinement statistics are presented in Table 5.  Structural Figure were made 
using UCSF Chimera.   
Mass Spectrometry Study of Single Turnover of FCP  
       Asp-AT (39.5 µM) was incubated in 50 mM ammonium bicarbonate buffer (pH 7.4) 
containing 15.8 mM FCP in a total volume of 200 µL at room temperature in the dark for 12 h. A 
similar control solution that did not contain FCP was also incubated. After 12 h, formic acid (5 
µL) was added to each solution, and both were centrifuged in a 0.5 mL 10 kDa MWCO 
centrifuge tube at 13400 x g for 20 min or until most of the solution had passed through. 
Triplicate deproteinated reaction mixtures from incubation of Asp-AT with FCP, or the control, 
were analyzed by HPLC-ESI-MS.  Ten µL of each mixture was injected on a Phenomenex Luna 
C18(2) column, 2.1 x 150 mm, and analyzed by a linear gradient at 200 µL/min from 10% buffer 
B to 90% buffer B over 15 minutes, where buffer A was water with 0.1% formic acid and buffer 
B was acetonitrile with 0.1% formic acid.  Eluent from the LC was split 1:4 so that 20% of the 
eluent (40 µL/min) flowed directly into a Thermo Ion Max ESI source connected to a Thermo Q-
Exactive.  Data was collected in negative ion mode through a data-dependent top five method 
where the first duty cycle scan was a global scan from 100 to 1000 Th, followed by MS2 
fragmentation of the five most abundant ions with the higher energy collisional dissociation cell 
set to a normalized collision energy of 45 arbitrary units.  Extracted ion chromatograms for ions 
of interest were generated and integrated for total peak area.  Peak areas from triplicate samples 
were averaged and error bars were generated based on standard deviation. 
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CONCLUSION 
Structural and biochemical characterization of AidC 
      Quorum-quenching enzymes are important biochemical tools for probing quorum-sensing 
pathways in bacteria. They also hold considerable promise as reagents to prevent marine and 
membrane biofouling, as treatments to prevent costly infections of plants and animals, and as 
tools to manipulate interactions between microbes7. However, the mechanism these enzymes use 
to recognize and process substrates is not well characterized. An understanding of their 
selectivity and catalytic mechanism would enable the production of enzymes that can recognize 
specific quorum-sensing signals to serve as more precise biochemical probes, and as a more 
promising catalysts for other applications. Several research papers report the characterization of 
a quorum quenching AHL lactonase from Bacillus sp., AiiA, and a general mechanism has been 
proposed for its catalytic mechanism13,15,. AiiA has KM values in the mM range and displays 
broad substrate specificity. The research conducted and detailed in the first part of this 
dissertation has provided information about the catalytic mechanism and selectivity of the 
quorum-quenching AHL lactonase from the potato root-associated Chryseobacterium sp. strain 
StRB126, AidC. 
      Steady state enzyme kinetics show AidC has an unusually low KM value for AHL substrates 
and displays a stricter substrate selectivity than any other related AHL lactonase characterized to 
date. To our knowledge, AidC also has the highest reported kcat/KM value for any characterized 
wild-type quorum-quenching enzyme, regardless of superfamily.  Structural determination of 
AidC alone, and with bound product, reveals an unusual ‘kinked’ helix and suggests a structural-
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basis for the enhanced selectivity. Intriguingly, AidC shows some structural similarities that 
more closely match families more distant from AHL lactonases, sharing a dimeric structure 
similar to an organic phosphotriesterase and an active-site histidine residue similar to that found 
in related phosphodiesterases. AidC serves as an example for understanding how quorum-
quenching enzymes can achieve selectivity between structurally similar AHL substrates, and 
may serve as an efficient catalytic template amenable to further optimization for a broad array of 
quorum-quenching applications. 
      To further probe the catalytic mechanism of AidC, mutation studies can be carried out based 
on the information reported in this dissertation. The active-site histidine residue in AidC has 
been proposed to be important for catalysis. The role of histidine can be confirmed by 
characterizing the histidine to alanine and histidine to tyrosine mutants. A mutation at the proline 
203 residue, which creates a ‘kink’ in one of the alpha helices that surrounds the substrate 
binding pocket, could provide information about substrate specificity. Further, X-ray 
crystallography studies using either the wild-type enzyme or newly generated AidC variants, 
with substrate analogs and transition state mimetics can be used to gain structural insight into the 
mechanism of AidC. 
Selective targeting by a mechanism-based inactivator against PLP-dependent 
aminotransferases 
     Ornithine aminotransferase (OAT) and γ-aminobutyric acid aminotransferase (GABA-AT) 
belong to the same evolutionary subgroup and share similar structural functional and mechanistic 
features23. Therefore, many molecules that bind GABA-AT are also known to bind OAT. Unlike 
GABA-AT, OAT has only recently been identified as a drug-target and consequently there are 
only a limited number of therapeutically viable molecules that target OAT. Previous research 
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efforts have shown that potent mechanism-based inactivators can be rationally designed 
against these PLP-dependent drugs-targets. However, one the remaining challenges is the lack of 
selectivity towards other PLP-dependent off-target enzymes like Aspartate aminotransferase 
(Asp-AT). The second part of this dissertation has provided information on the selectivity of a 
mechanism-based inactivator–FCP. The results show that FCP inactivates the two drug-targets 
OAT and GABA-AT via an enamine mechanism, but is an alternative substrate for an apparent 
PLP-dependent off-target, Asp-AT.   
      Structural determination revealed a ternary adduct at the active site formed between OAT, 
FCP and PLP. This data led to the conclusion that OAT is inactivated via an enamine 
mechanism, similar to the mechanism previously reported for the inactivation of GABA-AT by 
FCP. Kinetic assays show FCP does not inactivate or inhibit Asp-AT. Structural studies of Asp-
AT in complex with FCP and, in the presence and absence of α-ketoglutarate suggested FCP is 
an alternate substrate for Asp-AT.  A model has been proposed, where FCP turnover is 
partitioned between two separate pathways. High-resolution mass spectrometry studies support 
both pathways. Therefore, we conclude both pathways occur concurrently.  
       The proposed mechanisms of inactivation and alternative turnover in all three enzymes are 
complex, and all contain multiple reaction pathways. Although FCP is still too toxic to become a 
drug89,77 itself, it displays a desirable selectivity in the context of drug development as a 
mechanism-based inactivator.  The reason for this desirable selectivity is due to the subtle 
differences in the shapes of the active site cavities for retaining an intermediate, as well as the 
availability of a water molecule for a proposed hydrolysis in a complex mechanism with multiple 
reaction pathways. In general, the reactive intermediates generated during the complex reactions 
of these mechanism-based inactivators in active sites could be capable of displaying desirable 
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specificity of inactivation discerning drug targets and off-targets, even with similar structures 
and reaction mechanisms. 
     Most of the effort to design mechanism-based inactivators has focused on GABA-AT purified 
from pig brain. To our knowledge, active GABA-AT cannot be expressed and purified via 
recombinant methods. However, OAT has be grown and expressed in E. coli cells. Future studies 
could involve mutations in active site residues in OAT. These variants of OAT can provide 
information about selectivity and reaction mechanisms. This information can be used to design 
mechanism-based inactivators that are specific for one drug-target.  
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